ValueGuide Feb2010
ValueGuide Feb2010
CONTENTS
06 TRADER'S TECHNIQUES
Sharekhan Special 3 8 Sensex 39
35 Chana 42
PREMIER IDEAS
4 3 Smart Trades Ideas 44
Nifty Ideas 44
Derivatives Ideas 44
But the key drag on the equity markets globally and in India as well now are the growing concerns
related to the fragile economic condition of certain countries in Europe. It all began with Greece.
The Greek government’s inability to push through the Euro8 billion auction of government bonds
resulted in a spike in its credit default swap spreads. The contagion soon spread to the other fragile
European countries such as Portugal, Spain and Ireland, thereby spooking the global financial and
equity markets.
To add to our market’s woes, the recent economic data coming out of the USA also was unexpectedly
weak. For instance, the first-time jobless claims in the USA saw an increase of 8,000 to 480,000
against a forecast of a decline of 10,000 for the week ended January 31, 2010. Moreover, deficit woes
are weighing heavily on the USA as well. Though propped by the massive public spending unleashed
by the US government last year the US economy grew by 5.7% in the fourth quarter of 2009 (at the
fastest pace in six years), uncertainty regarding the state of the economy persists.
Apart from the global issues, all eyes will definitely be trained on the finance minister (FM) who
is scheduled to present the Union Budget for FY2011 on 26th of this month. It would be a tough
act of sustaining economic growth momentum in the face of growing global uncertainties and
addressing domestic issues of rising inflation and ballooning fiscal deficit at the same time. The
market would keenly watch for the fiscal slippage this financial year and the roadmap for fiscal
consolidation. Some of the other expectations are: a partial roll-back of fiscal stimulus in terms of
excise duty cuts done earlier and more clarity on the implementation of tax reforms, both the
direct tax code and the goods and services tax. We shall outline the key expectations from the
budget in our detailed pre-budget note soon.
Given the growing global concerns and the many domestic events and issues, we see a challenging
market environment over the next few months. This is in line with our view stated in the latest Market
Outlook report (“2010: A tale of two halves” released on January 2, 2010). However, we continue to
believe in the India growth story and remain bullish on the equity markets in the long term. Therefore,
long-term investors will do well to ride out the volatility and look upon corrections as an opportunity
to build a strong portfolio for handsome returns in the next sustained bull market.
BHEL 2,407 37.5 26.6 20.6 24.3 27.4 28.1 2,568 6.7%
Remarks: Bharat Heavy Electricals Ltd (BHEL) is a premier power generation equipment manufacturer and leading EPC company. It has emerged as the prime
beneficiary of the four-fold increase in the investments in the power sector in India.
BHEL currently has strong orders worth Rs134,000 crore on hand which provide revenue coverage for the next three to four years. With more than 80% of the
orders coming from the government and state utilities, the risk of order cancellation is minimal. The company is also looking at various new initiatives like
transmission, distribution and renewable energy for sustaining robust growth in its business in the long term. However, the key challenge for BHEL would be
the timely execution of projects.
The company’s programme to expand its capacity to 15GW is largely on track and the new capacity should be available from March 2010. In our view, the
stabilisation of the new capacity coupled with the de-bottlenecking of the supply chain would aid BHEL’s revenues to grow at a CAGR of 26% over FY2009-11
with the profits growing at a CAGR of 35% over FY2009-11E.
At the current market price the stock trades at 26.6x and 20.6x FY2010E and FY2011E earnings respectively. We continue to like BHEL because of its resilient
business model that is expected to provide the highest revenue and profit growth among the Sensex stocks. We, therefore, maintain BHEL amongst our Top
Picks and have a Buy recommendation on the stock.
DHAMPUR SUGAR MILLS 130 12.2 3.0 4.1 12.1 38.6 22.2 191 47.1%
Remarks: Dhampur Sugar Mills is the fifth largest sugar producer in India with integrated facilities and is going to be a key beneficiary of the current upturn in the sugar
cycle. We expect the profits to quadruple in FY2010 (ending September 2009) due to higher profits from its sugar business led by a higher sugar realisation,
and refining and sale of raw sugar imported at a low cost.
The hefty cash flow generation in FY2009-11 due to a rampant increase in its business profits will help the company to bring down its debt-equity ratio to 1x
in SY2010 and from 2.6x in SY2009. However, despite the stupendous profit growth the stock trades at 3.0x FY2010E earnings, which is at a steep discount
to its peers that are trading at ~7.5x their FY2010E earnings.
A higher than expected sugar-cane price, possible further government interventions and likelihood of a bumper sugar crop in FY2011 remain the key risks to
our estimates.
At the current market price of Rs130 the stock trades at 3.0x and 4.1x its FY2010E and FY2011E EPS respectively and 2.3x and 2.9x FY2010E and FY2011E
EV/EBIDTA respectively. We maintain our Buy recommendation on the stock with the price target of Rs191.
GODREJ CONSUMER 235 35.1 21.2 17.5 46.9 43.8 39.8 318 35.3%
Remarks: GCPL is a major player in the Indian FMCG market with presence in soap, hair dye and hair colour, liquid detergent and toiletry categories. The acquisition of 49%
stake in Sara Lee shall broaden the product portfolio and immensely improve the growth prospects of the company in the long run. With an increase in its reach
in the rural market, thrust on growing its market share in states other than north, GCPL will continue to gain market share in the soap and hair colour segments
and would post a steady volume growth in the coming quarters. Thus, we expect GCPL’s top line to grow at a CAGR of 17.9% over FY2009-12 (excluding Sara
Lee’s financials).
With a lower raw material cost, the margins of the company have improved substantially. Thus, we expect a hefty 63.8% y-o-y growth in its net profit in FY2010.
With strong cash flows GCPL has healthy cash on books (Rs400 crore as on March 31, 2009); further, the company recently took a board resolution to enable
it to raise up to Rs3,000 crore as it eyes big-ticket acquisitions. We believe acquisitions in the near term could act as additional triggers for the stock.
We believe a significant uptick in palm oil prices, increased competitive activity in the soap segment and the impact of high food inflation on the demand for
its products are the key risks to the company’s profitability.
With a 40.2% CAGR over FY2009-12 (including Sara Lee’s financials) GCPL will outperform the industry and remains one of the better performing companies
in the FMCG space. At the current market price the stock trades at 17.5x its FY2011E earnings. We have a Buy recommendation on the stock.
GREAVES COTTON 269 24.0 12.2 9.4 13.9 24.3 26.7 365 35.9%
Remarks: Greaves Cotton Ltd (GCL)’s core competencies are in three-wheeler diesel/petrol engines, power gensets, agro engines and pumpsets (the engine segment)
and construction equipment (the infrastructure equipment segment).
GCL is likely to be the key beneficiary of the uptick in the demand for the three-wheeler engines (which constitute 60% of the company’s total revenues). The
infrastructure equipment business (constitutes about 15% of the company’s total revenues) is a direct play on the growth in the construction and road building
activity in the country. We believe with much improved fund availability, low interest rates, and a pick-up in industrial and real estate sectors, the business is
in for a sharp revival.
GCL has a strong balance sheet and is a zero net debt company. Moreover, the company does not have any major capex plans in the near future. With a hefty
increase in its profits and a low capex the company is expected to generate free cash flows in excess of Rs100 crore in FY2010 and FY2011.
We believe that a slower than expected recovery in the construction and road building activity in the country could affect the revival of sales for GCL’s
construction equipment division and thus poses a risk to our estimates. Also, the lower than expected sales of three-wheelers by Piaggio (which accounts
for a high proportion of sales in the automotive engine division) may have a direct impact on the performance of the automotive engine segment.
We expect GCL to post a robust CAGR of 20.5% in revenues and that of 59.9% in its net profit over FY2009-11. At the current market price, the stock trades at
12.2x and 9.4x its FY2010E and FY2011E EPS respectively. We have a Buy recommendation on the stock.
ITC 250 29.1 23.2 19.9 25.3 27.2 27.0 303 21.1%
Remarks: ITC’s cigarette business that has dominance in the category continues to be a cash cow for the company. ITC endeavours to make a mark in the Indian FMCG
market with successful brands such as Bingo, Sunfeast and Aashirwaad, which are already reckoned among the best in the industry. With the company’s new
portfolio of personal care products its FMCG business competes with the likes of Hindustan Unilever and Procter & Gamble.
After a sharp increase in the excise duty on cigarettes in the last two Union Budgets, the government was less lethal in the Union Budget FY2009-10 and did
not increase the excise duty. This augurs well for ITC’s cigarette business and has led to a significant increase in its cigarette sales volumes. The rationalisation
of the company’s biscuit portfolio and an increase in the scale of its personal care business would further lower the losses in the non-cigarette FMCG business
going ahead. While the hotel business is staging a strong revival the agri-business’ profitability has improved sharply.
An increase in excise levy and the government’s intention to curb consumption of tobacco products remain the key risks to ITC’s cigarette business over the
longer term.
We expect ITC’s bottom line to grow at a CAGR of 20.0% over FY2009-12. At the current market price, ITC trades at 19.9x its FY2011E earnings. We maintain
our Buy recommendation on the stock.
LUPIN 1,421 22.1 18.6 15.1 37.5 29.0 27.4 1,602 12.8%
Remarks: Global dominance in certain products, focus on niche, less-commoditised products, a geographically diversified presence in newer markets, such as Japan,
and a presence in the US branded segment distinguish Lupin among the mid-cap players in the generic space.
With a leadership position in the anti-TB and other anti-infective segments, and a growing exposure to the chronic therapy segments, Lupin is one of the fastest
growing pharmaceutical companies in the domestic market.
A focus on niche products like oral contraceptives and ophthalmology products along with a strong presence in the branded space through a paediatric
antibiotic, Suprax, and a medical inhalation device, Aerochamber, has enabled Lupin’s US business to grow at a staggering CAGR of 77% over FY2004-08. With
the expansion in the branded portfolio through the recent addition of Antara and the launch of Allernaze, we expect the US branded business to grow at a CAGR
of 30% over FY2010-12.
With a strong business in India and the USA, Lupin has also made inroads into the other regulated markets of the UK and France. Further, it has entered markets
like Japan, Germany, Australia and South Africa through acquisitions in order to extend its global reach. We anticipate a CAGR growth of 37% in the emerging
markets over FY2010-12.
The strong core business and a differentiated strategy auger well for Lupin and now the clean chit of the Mandideep facility from the USFDA would drive the
performance of the stock.
We expect Lupin to report an earnings CAGR of 22% over FY2010-12 with strong margins at the operating level. At 18.6x FY2010E and 15.1x FY2011E earnings,
Lupin is among the cheapest front-line pharmaceutical stocks. We maintain our Buy recommendation on the stock with a price target of Rs1,602.
RELIANCE IND 1,047 21.5 20.1 14.2 12.3 12.4 14.9 1,148 9.7%
Remarks: With the start of the commercial production of gas in April 2009 and that of crude oil in September 2008 (both from the KG basin), Reliance Industries Ltd
(RIL) holds a great promise in the E&P business. The E&P business is expected to add significantly to the company’s earnings and to its cash flow from FY2010
onwards with the majority of the earnings coming from the less volatile natural gas business. The company is currently producing 60mmscmd of gas and
targets to ramp the output to 80mmscmd by the end of March 2010. At present, the company’s reserves are estimated at 9 billion barrels of oil equivalents.
We expect the gross refining margin (GRM) of RIL to contract in the near term, as new refineries with total capacity of 1.5-2.0 million barrel per day (including
Reliance Petroleum Ltd [RPL]) are expected to come on-stream in the environment of weak demand. However, we expect RIL to fetch a premium over
Singapore Complex’ GRM due to its superior refinery complexity and benefit of using captive gas from KG D-6. The refining volumes were also doubled as RPL’s
has been merged with RIL with effect from April 1, 2008.
We believe that RIL’s all cash but not binding bid to buy a controlling stake in the world’s third largest petrochemical company, LynodellBasell (LB), if successful
would have synergistic effect for RIL. It would help RIL gain access to LB’s ready market of USA and Europe. Further, after the deal RIL would become near
global monopoly in the polypropylene and polyethylene sectors. However, we await details on the bid price and the valuation.
We believe that RIL would be able to maintain superior margin in the petrochemical business, given its increased focus on the domestic market (a strong
demand and a high price realisation environment).
A delay in the ramp-up of the KG D-6 gas production and an adverse verdict of the Supreme Court of India on its legal feud with RNRL and another legal case
with National Thermal Power Corporation (NTPC) are the key risks to our estimates. Further, there is still ambiguity related to the likely change in the section
80IB, which could take away the benefit of the seven-year tax holiday from gas production. Any further fall in the refining and petrochemical margins could
result in deviation from our estimates.
At the current market price, the stock is trading at 14.2x FY2011E consolidated earnings.
SHIV VANI OIL & GAS 357 8.1 7.3 6.2 14.7 14.4 14.4 433 21.4%
Remarks: Shiv-Vani Oil & Gas Explorations is India’s largest onshore oil and gas service provider in the private sector having a fleet of 40 rigs and ten seismic survey
crews. The company offers a wide range of services including seismic, drilling and other specialised services, such as work over, gas compression services
and coal bed methane (CBM) integrated services.
The extremely strong order book of Rs3,700 crore, which is close to 4.2x its FY2009 revenues, renders strong visibility to the company’s earnings. The
company has gone for timely expansion of its assets in the past and all its assets are already backed by contracts in hand.
The company has shown an exponential growth in its financial performance in M9FY2010 and the same is likely to be maintained in the last quarter of the fiscal
with the deployment of all the eight rigs for a large order worth Rs1,610 crore from ONGC. The company is also planning to raise money (an amount not
exceeding UDS20 million or Rs100 crore) through the issue of new equity shares to Franklin Templeton. Further, the company is planning to raise additional
funds of Rs600 crore through a QIB issue to augment its fleet.
Softening day rates, and curtailment and deferment of worldwide E&P capex pose a risk to the company’s revenue going forward. Moreover, any delay in
contracts or any renegotiation of contracts going forward could potentially hamper its cash flows and thus remain a risk for the company. However, we see
little probability of renegotiation of the contracts, as the bulk of contracts are from public enterprises like ONGC and OIL.
At the current market price, the stock trades at 6.2x its FY2011E earnings. We maintain our Buy recommendation on the stock with a price target of Rs433.
TORRENT PHARMA 442 16.0 14.9 11.2 40.4 32.6 32.5 554 25.3%
Remarks: Torrent Pharmaceuticals (Torrent Pharma) is a well-known name in the domestic branded formulation market with strong focus on the fast-growing chronic
lifestyle segment.
Torrent Pharma has been one of the under-owned stocks in the mid-cap pharma space due to realignment in domestic formulations, impending turnaround
in the Heumann business and lower margins at the operating levels.
However, with the domestic market back on track, the completion of the investment phase in the emerging markets and the turnaround in the Heumann
business, we expect Torrent Pharma's earnings to post a CAGR of 24% over FY2010-12E. The cost restructuring initiatives will lead to operational efficiencies
in the long term, resulting in the expansion of the operating profit margins.
With the completion of the investment phase, robust field presence and new product introductions, we expect Torrent Pharma’s emerging market (Brazil,
Russia and Europe) business to post a strong CAGR of 19% over FY2010-12E. Further, a scale-up in the US business would add to its growth. We believe the
company has been trading at a significant discount (at 11.4x its FY2011E) to its peers and should get higher valuation.
We believe Torrent Pharma is on the right track for good revenue growth and a significantly higher earnings growth driven by margin expansion. At the current
market price of Rs442, the stock is discounting its FY2010E earnings by 14.9x and its FY2011E earnings by 11.2x. On account of continued traction in the
growth we maintain our Buy recommendation on the stock with a price target of Rs554.
Ideas
Sharekhan ValueGuide 11 February 2010
STOCK IDEAS Pratibha Industries
PRATIBHA INDUSTRIES
UGLY DUCKLING BUY; CMP: RS326 JANUARY 19, 2010
Orders galore, more to come
COMPANY DETAILS KEY POINTS
Price target: Rs450
Strong and diversified order book: Pratibha Industries (Pratibha) is one of the
fastest growing companies among the small construction companies. Its pend-
Market cap: Rs544 cr ing order book of Rs3,500 crore (over 4x FY2009 revenues) provides strong
visibility to its revenue growth. It also has a healthy order pipeline with “L1”
52-week high/low: Rs349/53
status in orders worth Rs900 crore. Apart from its strong position in irriga-
NSE volume (No of shares): 1.4 lakh tion and water management projects, it is also benefiting from its efforts to
diversify into high-growth segments such as urban infrastructure, power and
BSE code: 532718
oil & gas. Consequently, we expect its order book to grow at a CAGR of 53%
NSE code: PRATIBHA over FY2009-12.
Sharekhan code: PRATIND Backward integration provides an edge: Given its dominance in the water seg-
ment, Pratibha entered into the manufacturing of HSAW pipes in FY2008.
Free float (No of shares): 0.64 cr This backward integration enables the company to bid for pipeline related
projects at a very competitive rate. About 90% of the production is currently
SHAREHOLDING PATTERN
used in-house for its water projects and the balance is supplied to the oil & gas
segment.
Strong impetus on irrigation and water-management projects: Infrastructure
Institutions development would continue to be a secular growth story in India, and irriga-
18% tions and water management projects form a key component of the overall
government spending on infrastructure development in the country. As per the
planning commission, irrigation and water management projects constitute a
significant portion of the $500-billion worth of investments envisaged in infra-
Public & structure development in the 11th Five-Year Plan. The budgetary allocation
for this segment through various schemes like the AIBP, the Rajiv Gandhi
others Promoters
Drinking Water Project and the JNNURM has been stepped up significantly.
21% 61%
Cheapest among its peers: Pratibha enjoys superior operating profit margin
(12-13%) and return ratios compared with its peers. Its sales and net profit
have grown at a CAGR of 58% and 65% respectively over the last five years.
Going forward, we expect its sales and PAT to grow at a CAGR of 37% and
PRICE CHART
33% respectively over FY2009-12 led by healthy order inflows. Given its strong
400 growth outlook and relatively better return ratios, Pratibha is attractively val-
350 ued at 6.7x FY2011E earnings as compared to its peers. We recommend a Buy
300 on the stock with a price target of Rs450 (P/E multiple of 8x its average earn-
250 ings of FY2011E and FY2012E).
200 KEY FINANCIALS
150 Particulars FY2008 FY2009 FY2010E FY2011E FY2012E
100 Net sales (Rs cr) 565.1 805.8 1125.0 1578.9 2083.3
50
% y-o-y growth 88.1 42.6 39.6 40.4 31.9
0
Adj. net profit (Rs cr) 34.3 44.7 58.0 81.6 106.0
Jul-09
Jan-09
Jan-10
Oct-09
Apr-09
FY2009 ORDER BOOK BREAK-UP even the Punjab state government has earmarked Rs4,400 crore
for 131 cities in Punjab to revamp the water supply and sewerage
8% 1% system throughout Punjab. All this is likely to open up a glut of
11% projects that Pratibha could bid for.
The government has proposed to develop a National Gas Grid
which would facilitate the transportation of gas across the country.
Thus, Pratibha with its HSAW pipe manufacturing capacity is likely
20% 60% to benefit from the same.
INVESTMENT CONCERNS
Water & Irrigation Urban infrastructure Surface Trasport Timely execution of projects
Saw Pipe Hydro Carbon The bi ggest challenge for the construction companies is the timely
execution of projects as they have a long gestation period and require
huge capital outlay. Hence, their execution capability plays a very
Strong impetus on irrigation and water-management important role. With Pratibha’s order book 4x its FY2009 revenues,
projects timely execution would remain the key to its success. Any delay would
lead to cost overruns and affect the profitability of the company.
The government is committed to improve the infrastructure of the
country and has earmarked substantial funds for growth of the Cost escalation risk
sector. Infrastructure development would continue to be a secular Cement and steel are the key raw materials for the construction
growth story in India and irrigation and water management projects companies. Though Pratibha has a price escalation clause in all its
(the focus areas of Pratibha) form a key component of the overall projects, but the same protects its margins only to a certain extent.
government spending on infrastructure development in the country. Any further increase in the prices of the raw materials would hurt
As per the estimates of the Planning Commission, about USD500 the operating profit margin of the company.
billion needs to be spent over the 11th Five-Year Plan period of
2007-08 to 2011-12 on building India’s infrastructure. A growth Interest rate risk
of 2.2 times in investments is expected in the key infrastructure Infrastructure projects are capital intensive. Thus, any increase in
sectors during 2007-08 to 2011-12 as compared to that over the interest rates would put pressure on the company’s margins.
previous five-year period. Shortage of skilled manpower
Pratibha’s expertise lies in areas such as water supply and irriga- The anticipated shortage of skilled manpower could also delay the
tion, and urban infrastructure which are likely to grow at a faster
rate compared with the overall infrastructure sector. The govern- project execution, going forward. In FY2009, the company did not
ment had allocated Rs49,700 crore for the phase I of the Jawaharlal face any problem with skilled manpower. Going forward, with the
Nehru National Urban Renewal Mission (JNNURM) scheme and anticipated growth in the industry, there could be again a shortage
is planning to launch the next phase of the project with about of skilled manpower, which could hinder Pratibha’s revenue growth.
Rs100,000 crore of planned investments. The allocation for the
JNNURM scheme continues to be on the rise. In the Budget 2010, Valuations and view
the government had increased the spending on the JNNURM scheme Pratibha enjoys superior operating profit margin (12-13%) and
by 87% to Rs12,900 crore. return ratios compared with its peers. Its sales and net profit have
In the 11th Five-Year Plan the government has increased the planned grown at a CAGR of 58% and 65% respectively over the last five
outlay in irrigation by 2.3x to Rs253,301 crore. The government years. Going forward, we expect its sales and profit after tax (PAT)
had initiated major schemes such as Accelerated Irrigation Benefit to grow at a CAGR of 37% and 33% respectively over FY2009-12
Programme (AIBP), Bharat Nirman and Restoration of Water Bodies led by healthy order inflows. Given its strong growth outlook and
to ensure that there is an adequate supply of water for irrigation in
relatively better return ratios, Pratibha is attractively valued at 6.7x
order to maximise the performance of the agricultural sector. In the
budget 2010, spending on AIBP was marked up by 75% over the FY2011 earnings as compared to its peers. We recommend a Buy
last year and in the Rajiv Gandhi Drinking Water Mission the spend- on the stock with a price target of Rs450 (price/earnings [P/E] mul-
ing has been raised from Rs4,680 crore to Rs5,850 crore. Recently, tiple of 8x its average earnings of FY2011E and FY2012E).
FINANCIALS
PROFIT & LOSS A/C RS (CR) BALANCE SHEET RS (CR)
Particulars FY08 FY09 FY10E FY11E FY12E Particulars FY08 FY09 FY10E FY11E FY12E
Net revenue 565.1 805.8 1125.0 1578.9 2083.3 Share capital 17 17 17 17 17
Operating expenses 499.1 714.2 985.5 1386.3 1833.3
Reserves & Surplus 167 208 262 340 442
Operating profit 66.0 91.6 139.5 192.6 250.0
Shareholders fund 184 225 279 357 459
Other income 1.4 11.5 2.3 2.4 2.1
Total debt 133 248 288 388 468
Depreciation 3.6 7.1 14.2 20.0 25.2
Interest 23.6 40.5 44.8 58.4 75.5 Differed tax liability 2 6 7 8 9
PBT 40.2 55.4 82.9 116.6 151.4 Total liabilities 318 479 574 753 936
Tax 5.9 10.7 24.9 35.0 45.4 Gross block 99 168 268.32 348 428
Reported PAT 34.3 44.7 58.0 81.6 106.0 Net fixed assets 92 154 240.19 300 355
EPS 20.5 26.8 34.8 48.9 63.5 Capital work in progress 32 61 30 30 30
Investments 85 0 0.09 0 0
CASH FLOW STATEMENT RS (CR) Gross current assets 438 562 717.06 992 1,291
Particulars FY08 FY09 FY10E FY11E FY12E Gross current liabilities 328 298 413.27 570 740
Operating profit before 64.7 92.7 117.6 161.0 207.9 Net current assets 110 264 303.79 422 551
working capital changes Miscellaneous expenditure 0 0 0 0 0
Change in working capital 82.7 -145.0 -72.9 -117.2 -133.3
Total assets 318 479 574 753 936
Net cash from operations 147.4 -52.4 44.8 43.8 74.6
Capital expenditure -77.9 -98.6 -69.3 -80.0 -80.0 KEY RATIOS (%)
Sale/Purchase of -82.5 88.6 - - - Particulars FY08 FY09 FY10E FY11E FY12E
investments
Sales growth (%) 88.1 42.6 39.6 40.4 31.9
Net cash from investing -160.4 -10.0 -69.3 -80.0 -80.0
PAT growth (%) 68.3 30.6 29.7 40.7 29.8
Increase in share capital 58.8 - - - -
EPS growth (%) 44.1 30.6 29.7 40.7 29.8
Increase in debt -3.5 115.6 40.0 100.0 80.0
EBIDTA margin (%) 11.7 11.4 12.4 12.2 12.0
Others -25.8 -38.0 -48.7 -62.3 -79.4
Net cash from financing 29.5 77.7 -8.7 37.7 0.6 PAT margin (%) 6.1 5.6 5.2 5.2 5.1
Net change in cash 16.5 15.3 -33.2 1.5 -4.8 RoCE (%) 19.7 19.5 17.0 18.5 18.8
RoNW (%) 24.6 21.9 23.0 25.7 26.0
ONE-YEAR FORWARD PE (X) Debt equity (X) 0.7 1.1 1.0 1.1 1.0
4 0 .0 Working capital days 48.4 99.1 98.7 99.7 100.7
3 5 .0
3 0 .0
2 5 .0
KEY VALUATIONS
2 0 .0
Particulars FY08 FY09 FY10E FY11E FY12E
1 5 .0
1 0 .0
PER (x) 15.9 12.2 9.4 6.7 5.1
5 .0
P/BV (x) 3.0 2.4 2.0 1.5 1.2
0 .0 EV/EBITDA (x) 8.1 7.9 5.7 4.6 3.9
Mar-06
Mar-07
Mar-08
Mar-09
Jun-06
Sep-06
Jun-07
Sep-07
Jun-08
Sep-08
Jun-09
Sep-09
Dec-06
Dec-07
Dec-08
Dec-09
ALLAHABAD BANK
CANNONBALL HOLD; CMP: RS136 JANUARY 25, 2010
COMPANY DETAILS
Price target: Rs144
Healthy core performance
Market cap: Rs6,075 cr RESULT HIGHLIGHTS
52 week high/low: Rs145/37
Allahabad Bank has reported a net profit of Rs345.4 crore, down 6.5% y-o-y
NSE volume (No of shares): 14.7 lakh
BSE code: 532480 The NII for the quarter stood at Rs675.6 crore, up by 11.8% yoy and 12% qoq. The
growth was driven by a 13-bps q-o-q expansion in the reported NIM coupled with a
NSE code: ALBK
robust 8% advances growth on a sequential basis.
Sharekhan code: ALLBANK
Free float (No of shares): 20.0 cr The reported NIM expanded by 13 bps qoq to 2.97% during the quarter, mainly
driven by a 40 bps improvement in the cost of funds.
SHAREHOLDING PATTERN
Public & The non-interest income declined by 17% yoy to Rs339.5 crore, as the treasury income
others dropped by 54% yoy to Rs133.3 crore during the quarter.
16%
The provisions for the quarter came in at Rs246.3 crore, up 139% yoy on a lower base.
Foreign
13% Promoter
The advances grew by a strong 24% yoy while the deposits grew by 25.4% yoy.
56% The asset quality of the bank deteriorated in absolute terms during the same quarter. In
MF & FI absolute terms, the GNPA increased by 7.2% qoq to Rs1,160.5 crore.
15%
The CAR of the bank came in at 15% as at the end of Q3FY2010 and the same was
PRICE PERFORMANCE
largely in line with the CAR in the previous quarter.
(%) 1m 3m 6m 12m
Absolute 8.4 7.3 61.8 165.3
At the CMP of Rs136, the stock trades at 4.6x its FY2011E EPS, 2.2x FY2011E PPP
per share and 1.1x FY2011E ABV per share. We maintain our Hold recommendation
Relative to Sensex 7.4 6.7 41.8 37.0
on the stock with a price target of Rs144.
The author doesn’t hold any investment in any of
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
AXIS BANK
EMERGING STAR BUY; CMP: RS1,078 JANUARY 15, 2010
COMPANY DETAILS
Price target: Rs1,244
Upgraded to Buy
Market cap: Rs43,512 cr RESULT HIGHLIGHTS
52 week high/low: Rs1093/279
Axis Bank’s net profit in Q3FY2010 increased by 31% yoy to Rs656 crore—ahead of
NSE volume (No of shares): 23.2 lakh our as well as street’s estimates.
BSE code: 532215
NSE code: AXISBANK
The NII grew by 45.1% yoy and 17.3% qoq to Rs1,349.1 crore. The growth was on
account of reduction in the cost of funds to 4.12% in the quarter as against 6.2% in the
Sharekhan code: AXISBANK
same quarter of the last year.
Free float (No of shares): 24.7 cr
SHAREHOLDING PATTERN The non-interest income increased by 35% yoy to Rs988.1 crore.
Public & The provisioning expenses increased to Rs373.1 crore, as the bank continued to make
others
22% higher provisions on loan loss at Rs358 crore for the quarter. The provision coverage
Promoter ratio including technical write-off currently stands at 69.07%l.
39%
The asset quality was largely stable on sequential basis. In relative terms the %GNPA
increased to 1.23% from 1.21% in the previous quarter.
Foreign
MF & FI The advances grew by 12.5% yoy to Rs84,770 crore while the deposits grew by 7.7%
31%
8%
yoy to Rs113,853 crore.
PRICE PERFORMANCE
The capital adequacy ratio of the bank improved to 16.8%.
(%) 1m 3m 6m 12m
Absolute 7.2 3.3 39.7 140.9
At the CMP of Rs1,078, the stock trades at 14.1x 2011E EPS, 7.3x 2011E PPP and
2.4x 2011E BV. We are revising our price target to Rs1,244 and upgrade our recom-
Relative to Sensex 4.1 1.0 9.5 26.8
mendation from Hold to Buy.
The author doesn’t hold any investment in any of
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
BANK OF BARODA
APPLE GREEN BUY; CMP: RS522 JANUARY 27, 2010
COMPANY DETAILS
Price target: Rs589
Results above expectations
Market cap: Rs19,015 cr RESULT HIGHLIGHTS
52 week high/low: Rs568/181
For Q3FY2010, BoB has reported a bottom line of Rs832.5 crore, up by 17.5% yoy
NSE volume (No of shares): 6.8 lakh Importantly, the year ago quarter included one-time gain of Rs69 crore, excluding
BSE code: 532134 which the growth would have been even higher.
NSE code: BANKBARODA
NII stood at Rs1,601.2 crore, up by a healthy 9.5% yoy and 15% qoq. The sequential
Sharekhan code: BOB
improvement in the NII growth was possible due to expansion in the reported NIM to
Free float (No of shares): 16.8 cr
2.95% coupled with a healthy 23.5% y-o-y growth in the advances.
SHAREHOLDING PATTERN
The non-interest income dropped by 22.1% yoy to Rs659.7 crore though up by 11%
Public &
others on a sequential basis.
12%
Provisions dropped sharply by 30.7% yoy to Rs242.5 crore in the quarter.
Foreign
15% The asset quality deteriorated sequentially during the quarter. The GNPA increased by
Promoter
54% 16% qoq to Rs2,260.3 crore, as the bank booked non-performing assets (NPAs) of
MF & FI Rs212 crore from debt-waiver scheme (the deadline was December 2009) on a pruden-
19% tial basis. The provisioning coverage stood at strong 78.4%.
PRICE PERFORMANCE The bank’s capital adequacy ratio stood at 14.65% as on December 31, 2009.
(%) 1m 3m 6m 12m
At the current market price of Rs522, the stock trades at 6.0x FY2011E earnings per
Absolute 3.8 7.0 22.5 134.4 share (EPS), 3.2x FY2011E pre-provisioning profit (PPP) per share and 1.2x FY2011E
Relative to Sensex 7.4 7.1 11.8 19.7 book value (BV) per share. We maintain our Buy recommendation and price target on
the stock.
The author doesn’t hold any investment in any of
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
BHARTI AIRTEL
APPLE GREEN HOLD; CMP: RS321 JANUARY 22, 2010
COMPANY DETAILS
Price target: Rs350
Results in line with expectations
Market cap: Rs121,996 cr RESULT HIGHLIGHTS
52 week high/low: Rs495/229 Bharti Airtel Ltd (BAL)’s Q3FY2010 results were in line with our expectations. The
NSE volume (No of shares): 91.8 lakh consolidated revenues declined by 0.7% sequentially to Rs9,772.2 crore.The net profit
BSE code: 532454 fell by 4.8% quarter on quarter (qoq) to Rs2,209.7 crore in line with our estimate of
NSE code: BHARTIARTL Rs2,214.7 crore.
Sharekhan code: BHARTI The operating profit was down by 5.6% qoq to Rs3,911.2 crore led by a 6.5% sequen-
Free float (No of shares): 122.7 cr tial drop in the operating profit of the mobile business. The OPM contracted by 204
basis points qoq to 40%. Despite a 6.5% drop on the operating level, the sequential net
SHAREHOLDING PATTERN profit drop was arrested at 4.8% aided by forex gain of Rs148.6 crore
Public &
ARPM declined by 8% qoq at Rs0.52 and despite festive season the MoU showed a flattish
Others Foreign
2%
to negative stance at 446 minutes in Q3FY2010 as against 450 minutes in Q2FY2010.
18%
The revenues from the mobile segment declined by 1.7% on a sequential basis due to a
Institutions
8% q-o-q drop in the ARPM to Rs0.52, partially offset by a 6.8% q-o-q increase in the
8%
Non-promoter total MoU to 15,345 crore minutes. The ARPU for the quarter declined sequentially by
corporate 8.7% to Rs230 as against our estimate of Rs228.
Promoters
4%
68% Given the intense competition-led pricing pressure on the mobile business, we are now
factoring in a decline in the spread per minute. Further, we have also mellowed down
PRICE PERFORMANCE our revenue growth for the non-mobile. Our revised EPS for FY2010 and FY2011
(%) 1m 3m 6m 12m stands at Rs24.1 and Rs22.8 respectively, and are introducing our FY2012 estimates
Absolute 4.0 -3.1 -22.9 10.9 and expect BAL to report FY2012 EPS at Rs23.3.
Relative to Sensex 1.2 -3.4 -32.2 -43.6 At the current price, the stock trades at 14.1x its FY2011 estimated earnings and 7.3x
EV/EBITDA. We maintain our near-term cautious view on the sector and maintain
The author doesn’t hold any investment in any of Hold recommendation on the stock with a price target of Rs350.
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
CROMPTON GREAVES
APPLE GREEN HOLD; CMP: RS434 JANUARY 29, 2010
COMPANY DETAILS
Price target: Rs478
Price target revised to Rs478
Market cap: Rs15,908 cr RESULT HIGHLIGHTS
52 week high/low: Rs448/100 Crompton Greaves Ltd (CGL)’s Q3FY2010 standalone revenue went up by 13.3%
NSE volume (No of shares): 4.0 lakh year on year (yoy) to Rs1,223.8 crore. The growth was led by a 27.2% yoy growth in
BSE code: 500093 the consumer product division’s revenue. The industrial system division’s sales grew by
NSE code: CROMPGREAVE robust 19.6%. The power system division’s revenue was up by mere 4% as against our
Sharekhan code: CROMPTON
expectation of a 20% y-o-y growth.
Free float (No of shares): 20.1 cr The operating profit margin (OPM) improved to 16.6% versus 12.9% in Q3FY2009
on account of better operating efficiencies. Boosted by a operating performance, the net
SHAREHOLDING PATTERN profit jumped by 59.8% yoy to Rs135.4 crore.
Others
17% The consolidated net revenue went up by mere 4.5% to Rs2,246.4 crore, mainly on
Promoters account of a 4.4% y-o-y fall in its subsidiaries’ revenue. The OPM jumped to 14.2%
41% from 10.5% in Q3FY2009 on the back of better operating performance. Consequently,
Institutions the net profit of the group rose by whopping 62% yoy to Rs199.6 crore.
24% Post M9FY2010 results, we have revised our earnings per share (EPS) estimates
Foreign for FY2010 and FY2011 to Rs22.1 (Rs19.2 earlier) and Rs24.8 (Rs21.9 earlier)
18% respectively.
PRICE PERFORMANCE With its strong market positioning, the company is well poised to capture the strong
traction in demand for the power T&D products. Currently, CGL is trading at 17.5x
(%) 1m 3m 6m 12m
FY2011E earnings and 15.4x on FY2012 estimates. We have rolled over our target
Absolute 1.2 18.3 43.6 220.8 multiple of 18x to average of FY2011E and FY2012E EPS. We value CGL at a fair price
Relative to Sensex 7.7 18.0 34.4 79.9 of Rs478, which provides limited upside from the current level. Hence, we maintain our
Hold recommendation.
The author doesn’t hold any investment in any of
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
HDFC BANK
EVERGREEN BUY; CMP: RS1,691 JANUARY 15, 2010
COMPANY DETAILS
Price target: Rs1,860
Consistent as ever
Market cap: Rs76,981 cr RESULT HIGHLIGHTS
52 week high/low: Rs1836/774
HDFC Bank’s Q3FY2010 performance was largely in line with our expectations. The
NSE volume (No of shares): 8.4 lakh bank’s net profit grew by 31.6% yoy.
BSE code: 500180
The NII for the quarter grew by 12.4% yoy to Rs2,223.9 crore. The NII growth was
NSE code: HDFCBANK largely driven by an improved credit growth as well as a sequential expansion in the
Sharekhan code: HDFCBANK reported NIM.
Free float (No of shares): 34.7 cr The non-interest income declined by 9.2% yoy to Rs853 crore.
SHAREHOLDING PATTERN Provisions declined by 16% yoy to Rs447.7 crore. Of the total provisions of Rs447.7
Promoter crore, a major chunk (Rs437.9 crore) was towards loan loss provisions. Consequently,
Public &
others
24% the provisioning coverage stood improved at 72.4% compared with 70.3% in the
38% previous quarter.
MF & FI The asset quality of the bank improved on a sequential basis. The GNPA declined by
11% 3% qoq to Rs1974.1 crore. In relative terms, the %GNPA declined to 1.63% from
Foreign
1.76% in Q3FY2010.
27% Advances grew by 21.1% yoy to Rs119,613 crore. Meanwhile, the deposits grew by a
PRICE PERFORMANCE muted 6.9% yoy to Rs154,789 crore.
(%) 1m 3m 6m 12m The CAR stood at 18.3% compared with 15.7% during the previous quarter.
Absolute -4.2 -1.1 23.6 73.4 At the current market price of Rs1,691, HDFC Bank trades at 20.6x FY2011E earn-
ings per share (EPS), 10.5x FY2011E pre-provisioning profit (PPP) and 3.4x FY2011E
Relative to Sensex -6.9 -3.3 -3.1 -8.7
price-book value. We maintain our Buy recommendation on the stock with a price
The author doesn’t hold any investment in any of
target of Rs1,860.
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
ICICI BANK
APPLE GREEN BUY; CMP: RS853 JANUARY 21, 2010
COMPANY DETAILS
Price target: Rs1,026
Ready to shift gears
Market cap: Rs95,035 cr RESULT HIGHLIGHTS
52 week high/low: Rs984/253 ICICI Bank reported a net profit of Rs1,101 crore in Q3FY2010, indicating a decline
NSE volume (No of shares): 57.4 lakh of 13.4% yoy.
BSE code: 532174 The NII grew by 3.4% yoy as the bank continued to contract its advances book.
NSE code: ICICIBANK Meanwhile, the reported net interest margin (NIM) at 2.6% indicates a 10-basis-point
Sharekhan code: ICICIBANK expansion on a sequential basis.
Free float (No of shares): 111.4 cr The non-interest income too registered a de-growth (down 33.5% yoy to Rs1,673
SHAREHOLDING PATTERN crore), driven by weak treasury performance and muted fee income growth
Public & The bank continued its cost rationalisation efforts and managed to lower its operating
others expenses further by 21.4% yoy and 4.4% sequentially.
MF & FI
9%
25%
The bank witnessed a 3% sequential decrease in its GNPA. The %GNPA stood at
4.84% vs 4.69% in the previous quarter, while the %NNPA stood at 2.43%.
The advances dipped by 15.6% yoy and 6% qoq to Rs179,269 crore and the deposits
contracted by 5.5% yoy to Rs197,653 crore.
Foreign
66% The bank’s CAR as on December 31, 2009 was 19.4%
PRICE PERFORMANCE At the current market price of Rs853, ICICI Bank trades at 18x its FY2011E earnings
(%) 1m 3m 6m 12m per share (EPS), 9.1x FY2011E pre-provisioning profit (PPP) per share and 1.7x its
Absolute 8.5 -7.0 11.9 124.8 FY2011E stand-alone book value (BV) per share. We maintain Buy recommendation
on the stock with a price target at Rs1,026.
Relative to Sensex 3.7 -8.5 -3.2 15.6
INFOSYS TECHNOLOGIES
EVERGREEN HOLD; CMP: RS2,587 JANUARY 12, 2010
COMPANY DETAILS
Price target: Rs2,822
Price target revised to Rs2,822
Market cap: Rs148,342 cr RESULT HIGHLIGHTS
52 week high/low: Rs2629/1101
Infosys Technologies (Infosys)’ Q3FY2010 results were well above our and the street’s
NSE volume (No of shares): 13 lakh expectations mainly on the account of a higher than anticipated volume growth. Infosys’
BSE code: 500209 management surprised positively with a strong upward revision in its FY2010 earn-
NSE code: INFOSYSTCH ings per share (EPS) guidance to Rs106.85 to Rs107.06, which is significantly higher
Sharekhan code: INFOSYS than our and the street’s expectations.
Free float (No of shares): 47.9 cr In Q3FY2010 the consolidated revenues of Infosys grew by 2.8% sequentially to
SHAREHOLDING PATTERN Rs5,741 crore, which was above our estimate of Rs5,563 crore. The dollar term rev-
enues grew strongly by 6.8% quarter on quarter (qoq) to USD1,232 million and were
Public &
Others
significantly higher than the company’s guidance of USD1,155-1,165 million.
16% The operating profit margin (OPM) improved by 90 basis points sequentially to 35.5%
during the quarter despite a salary hike. The net income grew by 2.8% sequentially to
Promoters
16% Foreign Rs1,582 crore in Q3FY2010 and was well above our expectation of Rs1,488 crore.
56%
Non-promoter In terms of the guidance for Q4FY2010, the EPS is expected to decline by 7.4-6.6%
corporate Institutions sequentially to Rs25.62-25.83. The margins are also expected to be negatively affected
4% 8% by 150 basis points sequentially in Q4FY2010 on the back of the wage hike and the
PRICE PERFORMANCE appreciation of Indian Rupee against the US Dollar.
(%) 1m 3m 6m 12m We have revised our EPS estimates to Rs107.7 and 119 for FY2010 and FY2011 respectively.
Absolute 1.2 14.8 45.3 109.5
We have also introduced our FY2012 estimates and expect EPS of Rs137.6 for the year.
Relative to Sensex -1.2 8.8 11.3 11.1 We maintain our Hold recommendation on the stock with a revised price target of
Rs2,822. At the current market price, the stock is trading at 21.7x its FY2011 and
The author doesn’t hold any investment in any of
18.8x its FY2012 earnings estimates.
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
ITC
APPLE GREEN BUY; CMP: RS255 JANUARY 25, 2010
COMPANY DETAILS
Price target: Rs303
Upgraded to Buy
Market cap: Rs96,773 cr RESULT HIGHLIGHTS
52 week high/low: Rs271/156 ITC’s Q3FY2010 results were ahead of our as well as the street’s expectations on the
NSE volume (No of shares): 43 lakh back of a healthy performance by all its businesses. The net sales grew by 18.7% yoy of
BSE code: 500875 Rs4,580.2 crore.
NSE code: ITC The decline in the losses of the non-cigarette FMCG business coupled with the higher
Sharekhan code: ITC margins in the agribusiness, and the paperboards, paper and packaging business re-
sulted in a 157-basis-point y-o-y improvement in the OPM. The operating profit grew
Free float (No of shares): 63.1 cr by 23.9% yoy to Rs1,707.6 crore.
SHAREHOLDING PATTERN The other income stood at Rs159.1 crore as against Rs97.6 crore in Q3FY2009. Thus,
Others the healthy operating performance across the businesses along with the higher other
12% income resulted in a 26.7% y-o-y growth in the reported net profit to Rs1,144.2 crore.
Non-promoter We believe the sustenance of a strong volume growth in the cigarette business, the
5% higher growth trajectory of the non-cigarette FMCG business, the improved prospects
of the hotel business and the sustenance of higher exports in the agribusiness would
Foreign &
help ITC’s revenue to grow at 15% compounded annual growth rate (CAGR) over
Institution FY2009-12. The lower losses in the non-cigarette FMCG business, improved profit-
83% ability in the hotel business and the sustenance of higher margins in the agribusiness,
and the paper, paperboard and packaging business, the bottom line is expected to
PRICE PERFORMANCE grow at a CAGR of 20.0% over FY2009-12.
(%) 1m 3m 6m 12m At the current market price of Rs254.9 the stock trades at 23.7x its FY2010E EPS of
Absolute 1.2 0.5 14.3 48.6 Rs10.8 and 20.2x its FY2011E EPS of Rs12.6. We revise our price target upwards as
we roll forward our target price to Rs303 based on 22x average of our FY2011 and
Relative to Sensex 0.2 0.0 0.1 -23.3 FY2012 EPS estimates. In view of the significant correction in the stock price and the
potential upside of ~19% from the current levels, we upgrade our recommendation
The author doesn’t hold any investment in any of from Hold to Buy.x.
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
LUPIN
APPLE GREEN BUY; CMP: RS1,420 JANUARY 29, 2010
COMPANY DETAILS
Price target: Rs1,602
Price target revised to Rs1,602
Market cap: Rs12,733 cr RESULT HIGHLIGHTS
52 week high/low: Rs1,564/549 Lupin’s performance in Q3FY2010 was encouraging & above expectations. The rev-
NSE volume (No of shares): 2.6 lakh= enues grew by 30.5% yoy to Rs1,255.4 crore driven by a strong traction across ad-
BSE code: 500257 vanced formulation sales (up 23.5% yoy), a healthy growth in the domestic formula-
NSE code: LUPIN tion business (up 18.5% yoy) and higher revenues from the Japanese market (up 13%
Sharekhan code: LUPLTD
yoy). The API segment also surprised positively (up 28.3% yoy).
The OPM expanded by 360bps to 19.6% due to lower other expenditure (down by
Free float (No of shares): 4.7 cr
390 bps yoy). This led the operating profit to grow by 60% yoy to Rs246.4 crore.
SHAREHOLDING PATTERN Lupin continues to revamp its entire drug discovery programme and has invested
Public Foreign
~Rs93.9 crore in Q3FY2010.
10% 17% With strong operating performance, the net profit grew by 37.9% yoy to Rs160.6
crore. However the tax growth was higher than expected.
Institutions
Lupin is increasing its focus on the branded business in the USA—its largest geogra-
Promoter 24% phy. Lupin has guided for a top line growth of 25-30% for the next two years with the
47%
Non-
bottom line growth of ~40%. The strong guidance is on the back of strong growth
promoter expected in the USA, domestic formulation business and Japan.
2%
Lupin is likely to witness a gradual improvement in the underlying fundamentals led by
PRICE PERFORMANCE an expanding US generics pipeline, niche/Para-IV opportunities in the US, strong per-
(%) 1m 3m 6m 12m
formance from Suprax, ramp-up in Antara revenues and traction in formulation rev-
enues from its European initiative. We expect Lupin to record 19% sales and 22%
Absolute -4.1 20.1 48.0 152.9 earnings CAGR for FY2010-12.
Relative to Sensex 2.1 19.8 38.5 41.8 At the CMP of Rs1,421, the stock trades at 15.1x FY2010E fully diluted earnings and
12.6x FY2011E fully diluted earnings. We maintain Buy with a revised price target of
The author doesn’t hold any investment in any of Rs1,602.
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
MARICO
APPLE GREEN HOLD; CMP: RS98 JANUARY 28, 2010
COMPANY DETAILS
Price target: Rs110
Results in line with expectations
Market cap: Rs5,968 cr RESULT HIGHLIGHTS
52 week high/low: Rs113/56
The key highlight of Marico’s Q3FY2010 result was sustenance of strong volume growth
NSE volume (No of shares): 3.5 lakh in its focus brands. Despite a strong 14%y-o-y growth in volumes, the net sales rose by
BSE code: 531642 only 7.8% yoy to Rs669.6 crore, as the price cuts/promotional add-ons implemented by
NSE code: MARICO the company to sustain a strong volume growth resulted in lower value sales.
Sharekhan code: MARICO
A lower y-o-y raw material cost resulted in a 201-basis-point improvement in the OPM
Free float (No of shares): 22.2 cr
to 14.8%. The OPM expansion was however capped by higher spends towards adver-
SHAREHOLDING PATTERN tisement and promotional activities, and other expenses. Thus the operating profit
Others grew by 24.8% yoy to Rs98.8crore.
8% Thus despite a higher single-digit growth in the top line, the adjusted net profit grew by
a strong 29.3% yoy to Rs65.7crore, in line with our estimat of Rs69.4 crore.
Institutions
29% We broadly maintain our profit estimates for FY2010 and FY2011 despite marginally
Promoters tweaking down the sales to factor in the lower value growth on account of price defla-
63% tion as we factor in a marginally higher OPM for the company.
Though we expect a good 20.3% CAGR in the adjusted net profit over FY2009-12,
PRICE PERFORMANCE the risks of a slowdown in the volume traction and the contraction in margin have
(%) 1m 3m 6m 12m increased significantly. Thus, while we are rolling forward our price target based on the
Absolute -6.4 1.5 11.6 65.8 average of FY2011 and FY2012 earnings, we are reducing the exit multiple from 22x
to 20x and accordingly our price target stands at Rs110. At the current market price of
Relative to Sensex -0.2 1.8 4.8 -9.5
Rs98.4 the stock trades at 19.7x and 16.5x its FY2011E and FY2012E earnings. We
The author doesn’t hold any investment in any of
maintain our Hold recommendation.
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
PRICE PERFORMANCE RIL ramped up its gas production at the KG D-6 block (D1 and D3 fields) to 60
mmscmd in Q3FY2010. The company has said that the design capacity of the KG D-6
(%) 1m 3m 6m 12m
gas production facilities has achieved a flow rate of 80mmscmd.
Absolute 3.4 -1.3 7.3 86.6
We have revised our price target to Rs1,148. We maintain our Hold recommendation
Relative to Sensex 2.4 -1.8 -6.0 -3.6
on the stock. At the current market price, the stock trades at a price/earnings ratio of
12x FY2012 earnings and an enterprise value (EV)/EBIDTA of 6.8x FY2012.
The author doesn’t hold any investment in any of
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
Institutions The company’s current order book of around Rs3,700 crore (though flat on a sequen-
8%
tial basis) is 4.2x its FY2009 revenues and increases its earnings visibility. Further, the
Promoters Non-promoter
54%
company is optimistic of winning new orders from ONGC and OIL.
corporate
16% We have fine-tuned our EPS estimates to Rs49 and Rs57.9 for FY2010 and FY2011
PRICE PERFORMANCE respectively. We have also introduced our FY2012 estimates in this note and expect
(%) 1m 3m 6m 12m
EPS of RS65.6 for the year.
Absolute 4.2 10.8 8.4 241.3 At the current market price, the stock is available at 5.4x its FY2012E earnings and an
Relative to Sensex 11.1 11.2 1.8 86.4 enterprise value (EV)/earnings before interest, depreciation, tax and amortisation
(EBIDTA) of 5.1x. We maintain our Buy recommendation and price target of Rs433
The author doesn’t hold any investment in any of for the stock.
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
TORRENT
ZYDUSPHARMACEUTICALS
WELLNESS
UGLY DUCKLING BUY; CMP: RS444 JANUARY 28, 2010
COMPANY DETAILS
Price target: Rs554
Price target revised to Rs554
Market cap: Rs3,752 cr RESULT HIGHLIGHTS
52 week high/low: Rs448/123 Torrent Q3FY2010 performance was broadly in line with our estimates. The adjusted
NSE volume (No of shares): 2.0 lakh PAT remained flat at Rs83 crore. The revenue growth (up 11%) at Rs480.1 crore was
BSE code: 500420 driven by strong growth across international businesses and steady traction in the
NSE code: TORNTPHARM domestic formulation business.
Sharekhan code: TORRPH Torrent has identified domestic operations along with Brazil, US and Mexico geogra-
Free float (No of shares): 2.4 cr phies as its key growth drivers in the foreseeable future. In Q3FY2010, Torrent posted
robust sales growth in USA (up 239% on a lower base), Brazil (up 34.1%) and RoW
SHAREHOLDING PATTERN (up 17.1%) on the back of volume growth with robust growth (up 14.5%) in the
Foreign domestic formulation business.
7%
Public Institutions
7%
Russia continued to crumble under pricing pressure and liquidity crunch (down 42.3%)
9%
Non-promoter
along with Heumann (down 17.7%). Given the fact that already 60% of the German
6% market is tender driven we think Germany will continue to be a challenging proposition
for Torrent in the foreseeable future. Torrent’s cautious approach in Russia also re-
stricts any growth at least in the next few quarters.
Promoter
71% The OPM remained flat in Q3 at 22.8%. The 260bps improvement in the gross margin was
offset by the increasing staff cost (up by 200bps). With higher domestic formulation growth,
PRICE PERFORMANCE faster growth in Brazil, rising scale in RoW markets and focus on new products in other
(%) 1m 3m 6m 12m geographies like the USA, Torrent is well placed to expand its margins going ahead.
Absolute 5.0 34.1 120.1 231.2 We expect the revenue to show a CAGR of 13% over FY2010-12 and the adjusted
Relative to Sensex 11.9 34.5 106.9 80.8 earnings to exhibit a CAGR of 24% over the same period. At the CMP of Rs444,
Torrent is discounting its FY2010E earnings by 15.0x and its FY2011E earnings by
The author doesn’t hold any investment in any of 11.2x. We maintain Buy with a revised price target of Rs554.
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
ZYDUS WELLNESS
EMERGING STAR BUY; CMP: RS279 JANUARY 25, 2010
COMPANY DETAILS
Price target: Rs342
Upgraded to Buy
Market cap: Rs1,090 cr RESULT HIGHLIGHTS
52 week high/low: Rs301/52 Zydus Wellness’ Q3FY2010 results were above our expectations on the back of ro-
BSE volume (No of shares): 88,706 bust performance of all its brands—Sugar Free, Ever Yuth and Nutralite.
BSE code: 531335 The net sales grew by a strong 41.7% year on year (yoy) to Rs75.1 crore. While Sugar
Free maintained its strong leadership position with an 81% market share in the sharply
Sharekhan code: CARNUT
growing category, Nutralite registered a strong revenue growth on the back of overall
Free float (No of shares): 1.1 cr good demand that was further aided by shortage of butter in the market. Ever Yuth
SHAREHOLDING PATTERN continued the growth traction witnessed in H1FY2010.
Others With benign raw material cost and a 208-basis-point y-o-ydecline in the other expenses
12% as percentage to sales, the operating margin jumped by 741 basis points yoy to 20.5%.
Institutions Consequently, the operating profit went up by 93.7% yoy to Rs20.7 crore and the
16% adjusted net profit grew by a stellar 105.5% yoy to Rs14.3 crore
To factor in the higher-than-earlier anticipated sales growth rates, the higher-than-
Promoters earlier expected margins on account of higher scale of operations and the tax benefits
72% to accrue from the new facility, we have revised our earnings estimates upwards. Con-
sequently, our EPS estimates for FY2010, FY2011 and FY2012 stand increased from
PRICE PERFORMANCE Rs9, Rs11.7 and Rs14.4 to Rs10.4, Rs15.5 and Rs22.5 respectively.
(%) 1m 3m 6m 12m At the current market price of Rs279, the stock trades at 26.8x, 18x and 12.4x its
Absolute -1.7 42.1 124.0 281.4 FY2010E, FY2011E and FY2012E earnings respectively. In line with the upgrade in
Relative to Sensex -2.6 41.3 96.3 96.9 our earnings estimates, we are upgrading our price target to Rs342 at 18x average of
FY2011E and FY2012E EPS. We are also upgrading our recommendation on the
The author doesn’t hold any investment in any of stock from Hold to Buy.
the companies mentioned in the article. For further details, please visit the Research section of our website, sharekhan.com
For further details, please visit the Research section of our website, sharekhan.com
Elliott wave theory, the market has completed wave A with a 5 wave 19500
19000
P 18500
the target of 12700 in wave C with reversal pegged at 17776. Over 16500
16000
15500
all, the Indian stock market has now gained its downside momen- 15000
14500
12500
On the weekly chart, the index suggests weakness in the momen- 12000
11500
tum indicator KST, which has given a negative crossover and also 11000
10500
shows negative divergence. The index has slipped below its 20 weekly 10000
moving average (WMA) for the first time since March 2009 and is 9500
9000
right now retracing the rise from 7697 to 17776. It is expected to 8500
retrace 50% of the rise form October 2008 to January 2010 i.e. 8000
7500
12700. On the daily chart, the index has fallen in a 5-wave pattern
D 2007 M A M J J A S O N D 2008 M A M J J A S O N D 2009 M A M J J A S O N D 2010 M A M J J A S O N D 20
and the momentum indicator is trading below the zero line, which
suggests weakness for a short-term target of 15500. WEEKLY CHART
- NSE50 [NIFTY] (4,882.05, 4,951.15, 4,708.15, 4,712.90, -174.450)
5500
0.0%
The key resistance for the Sensex will be 20WMA i.e. 16600. On 5000
the contrary, if the market sustains above this average, the pullback 23.6%
4500
i.e. 17000 and 17370 respectively. The index on the way down has 50.0%
4000
formed lower lows and lower tops while falling in a 5-wave fashion 61.8%
3500
with two negative weekly closes and is currently trading around the
lower Bollinger band on the daily chart. This indicates that a furi- 3000
ous move on the downside is now pending before the Indian equity
bellwether starts a new cycle on the upside. 2500
100.0%
KST (-1.28178) 40
30
20
10
0
-10
-20
-30
May Jun Jul Aug Sep Oct Nov Dec 2009 Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2010 Feb Mar Apr
2600
pattern. As a follow through of the pattern, guar seed fell sharply in the 2550
2500
3000
2900
2450
last month. Switching from bird’s eye view to worm’s eye view, the 2400
2350
2800
2700
2300
weekly chart reveals that the fall is taking place in a five wave fashion. 2250
2200
2600
2500 2500
Currently, guar seed is in wave 4 of the decline. However, as per the 2150
2100 2400
2050
principle of alternation, since wave 2 was a sharp one, the top of wave 4 2000
1950
2300
2235 2200
is already in place near 2500. Thus the commodity will now come down 1900
1850 2100
1800
to form wave 5. The target for wave 5 in accordance with the wave 1750
2000
1700
principle guidelines is nothing but equality with the wave 1 i.e. Rs2,235. 1650
1900
1600 1800
This will bring guar seed near its 50 daily exponential moving average 1550
1700
1500
(DEMA) as well as the channel equality. Bringing in another technical 1450
1600
tool, the weekly MACD, further strengthens the view. The weekly MACD 1400
1350 1500
is already in sell mode and as the commodity will head towards its target, 1400
30000
the indicator would come near the equilibrium line and would be set to 20000
10000
x100
posted record annual gains in the previous year. Technically, the MCX Copper (MONTHLY) 400
390
380
10
0
370 -10
-30
340
monthly chart—a bearish reversal sign. The lows have also been Q Engulfing Bear 330
320
-40
310
breached in the present month validating the bearish outlook. The 300
290
400
H
red metal has broken all key bullish trend lines clearly signaling a 280
270
0.0%
S
350
260
220
38.2%
ish reversal. We now expect the metal to retrace the entire rise from 210 50.0%
245 250
200
December 2008 to January 2010. In the near term, copper can take 190
61.8%
170
200
Rs290 and can marginally breach it to test the important swing 160
150
140
Rs310 where a head and shoulders (top reversal) pattern can be 130
100.0%
formed. The target for the pattern is pegged at Rs245, which is also M A M J J A S O N D 2009 M A M J J A S O N D 2010 M A M J J A A M J J A S O N D 2009 M A M J J A S O N D 2010 M A M J J
50% retracement of the one-year bull run. The metal is also consid-
ered to be a leading barometer for the economic trend, which again
points to a weak first half for the global economy.
DERIVATIVE VIEW
The January series started on a optimistic note and made a 52-week Top five stock futures with the highest open interest in the current
high in both the Nifty and the Sensex in the early part of the series, series are:
but that optimism was short-lived and global factors coupled with STOCK FUTURES OPEN INTEREST (RS CRS)
a lot of events within the country dragged the Nifty sharply down
Reliance 1,617.7
to 4800. The January series finally closed with a loss of around
Tata Steel 1,440.4
6.5%. Roll-overs in this series were lower than that in the previous
SBIN 1,264.4
expiry in stock futures whereas the same were higher in Nifty fu-
ICICI Bank 1,130.5
tures, indicating a low-risk appetite among the market participants
at the current juncture and significant short roll-overs in the Febru- TATA Motors 1,038.7
ary series may lead to higher volatility with a downward bias. Top five stock options with the highest open interest in the current
series are:
On the option side we have seen that the implied volatility has taken
a sharp u-turn from a low of 18% to around 28-29%, indicating STOCK OPTIONS OPEN INTEREST (RS CRS)
volatility may rise in the days to come. The activity on the option Reliance 403.7
side remains on the higher side with 4,900-5,100 strike prices being SBIN 339.1
the most active on the call side and 4900-4700 the most active on NTPC 315.5
the put side. Option analysis indicates that 4730 should act as a TATA Steel 247.9
very good support level for the month whereas on the higher side ICICI Bank 232.8
5040 will act as a very good resistance and can be considered as a Strategy for the month:
trend reversal. We expect this month to be highly volatile with limited upside. One
can sell out of money call option with a strict stop loss at 5040 on
a closing basis.
3100 4000
2900 3800
3000
15% 2600
2700
2500 2000
2300 1000
2100 2200
0
1900
Jul-06
Jul-07
Jul-08
Jul-09
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
Oct-05
Oct-06
Oct-07
Oct-08
Oct-09
Apr-06
Apr-07
Apr-08
Apr-09
1700
1500
Jul-08
Jul-09
Jan-08
Jan-09
Jan-10
Oct-08
Oct-09
Apr-08
Apr-09
2000
500
1500
1000 0
Jul-05
Jul-06
Jul-07
Jul-08
Jul-09
500
Jan-06
Jan-07
Jan-08
Jan-09
Jan-10
0
Oct-04
Oct-05
Oct-06
Oct-07
Oct-08
Oct-09
Apr-04
Apr-05
Apr-06
Apr-07
Apr-08
Apr-09
Sowing of pulses other than chana too has been well this year--
Falling in line with our view chana as well as other pulses has been thanks to sky-rocketing prices. Sowing of lentils is reported at 15.18
trading in a negative trajectory. The price correction has been led lakh hectare, higher than that of 14.66 lakh hectare in the last year.
stock limits imposed by the government, higher pulses acreage this Acreage of Urad at 7 lakh hectare is also higher than that of 5.5 lakh
Rabi season, higher supply of Kharif pulses mainly Tur and un- hectare in the last year. On the whole, Rabi pulses sowing this year
interrupted supply from overseas markets mainly from Canada stands at 136 lakh hectare, higher than 128 lakh hectare last year.
and Australia.
Fresh supply of tur
Current scenario
Harvesting of the new Tur crop has begun from the first week of
Chana crop this season
January. Tur has corrected following a higher crop size in India as
Sowing has ceased and fresh crop harvesting has begun in certain well in international markets. New Tur crop is currently quoting at
parts of central India. Acreage this year stands at 87 lakh hectare, Rs4,000 per quintal, lower than Rs5,900 in October 09. The crop
higher from 83 lakh hectare last year. Given the congenial weather size this year is forecast at 24.7 lakh tonne, slightly higher than the
in central India, we expect production this year to be around 75-77 last year’s 24 lakh tonne.
lakh tonne with the productivity improving by around 5-6 %. The
As a matter of fact, sowing of kharif crops too has seen a jump this
fresh supply would augment in March while peaking in April and
the days to come would see chana come under seasonal pressure. year; however, a major impact on prices was not noticed since crop
harvesting for the main kharif pulse Tur begins in January. Cumu-
Supply of Rabi pulses lative sowing of kharif pulses has been recorded at 98 lakh hectare,
SOWING IN RABI 2009-10 (ACREAGE IN LAKH HECTARES) higher than 93 lakh hectare sown in the last year.
2009-10 2008-09 A record sowing coupled with fresh imports from Canada and
Chana 86.75 82.31 Australia has weighed on prices. Prices of other pulses too is fore-
Masur 15.18 14.66
cast to be on a defensive note in the coming days.
Urad 6.96 5.43
Moong 4.74 3.85
others 22.68 22.57
Total 136.31 128.82
PREMIER IDEAS
PRODUCT DETAILS (FOR JANUARY 2010)
Product Ticket Size No Of calls Profit / Loss (Rs) Profit/ Loss (%)
DERIVATIVES IDEAS
These ideas are generated by Sharekhan Derivatives Desk based on the analysis of open interest in the market and the other
indicators. It is a leveraged product and ideal for aggressive traders. These ideas are reported on a daily basis. A monthly report
shall also be released.
NIFTY IDEAS
In this, trading ideas are generated in the Nifty (both short and long) based on technical study. It is meant for aggressive traders
wanting to actively trade on the market indices. These ideas are reported on a daily basis. A monthly report shall also be released.
If you do not have time to monitor the market tick by tick, to shift through pages of research or to pour over complex charts, then
Premier Ideas are what you need.
DISCLAIMER: “This document has been prepared by Sharekhan Ltd.(SHAREKHAN) This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed
to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute
an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all the customers simultaneously, not all customers may
disclaimer
receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report. The information contained herein is from publicly available data or other sources
believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and
affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not
represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken
as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive
at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits
and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan
may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any
person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which
would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain
category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. SHAREKHAN & affiliates may have used the information set
forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from
time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any
third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily
reflect those of SHAREKHAN.”
Evergreen
HDFC 2,390.0 11,017.7 11,526.2 14,167.1 2,282.5 2,716.3 3,272.2 80.2 95.5 115.0 20% 29.8 25.0 20.8 - - 19.5 20.6 30.0 1.3
HDFC Bank 1,573.0 10,711.8 11,969.3 14,374.8 2,244.9 2,936.6 3,836.4 52.8 62.8 82.1 25% 29.8 25.0 19.2 - - 16.7 17.4 10.0 0.6
Infosys Tech 2,354.0 21,693.0 22,825.0 25,742.0 5,880.0 6,158.0 6,805.0 102.8 107.7 119.0 8% 22.9 21.9 19.8 35.2 32.9 27.4 25.0 23.5 1.0
Larsen & Toubro 1,425.0 40,187.0 43,501.6 56,485.3 3,776.0 4,720.5 5,720.3 48.6 62.9 78.6 27% 29.3 22.7 18.1 16.5 17.2 19.8 19.0 8.5 0.6
Reliance Ind 979.7 151,224.0 187,478.0 250,986.4 15,299.0 17,124.5 24,169.7 48.6 52.1 73.5 23% 20.1 18.8 13.3 10.1 12.4 12.4 14.9 6.5 0.7
TCS 722.9 27,813.0 30,186.0 33,416.0 5,172.0 6,706.0 7,640.0 26.4 34.3 39.0 22% 27.4 21.1 18.5 29.5 28.5 35.0 32.7 5.0 0.7
Apple Green
Aditya Birla Nuvo @ 828.8 4,786.2 5,026.4 5,477.6 137.4 209.6 260.4 14.5 18.5 22.9 26% 57.3 44.8 36.2 19.4 21.6 3.9 4.7 4.0 0.5
Apollo Tyres*** 52.4 4,984.1 7,853.9 9,068.8 139.2 425.3 378.7 2.8 8.4 7.5 64% 18.7 6.2 7.0 28.3 21.4 22.4 16.7 0.5 1.0
Bajaj Auto 1,698.0 8,776.2 11,921.0 14,475.0 820.7 1,754.0 1,866.0 56.7 121.3 129.0 51% 29.9 14.0 13.2 62.3 51.5 68.4 46.5 22.0 1.3
Bajaj Finserv 341.2 385.3 - - 71.3 - - 4.9 - - - 69.6 - - - - - - 1.0 0.3
Bajaj Holdings 551.1 221.6 - - 174.8 - - 21.8 - - - 25.3 - - - - - - 10.0 1.8
Bank of Baroda 560.0 7,881.1 8,631.4 10,814.6 2,227.2 2,832.2 3,161.0 60.9 77.5 86.5 19% 9.2 7.2 6.5 - - 20.2 19.3 9.0 1.6
Bank of India 335.0 8,550.8 8,391.8 10,235.5 3,007.3 1,816.5 2,556.7 57.2 34.5 48.6 -8% 5.9 9.7 6.9 - - 14.5 17.8 8.0 2.4
Bharat Electronics 1,950.6 4,583.6 5,441.9 6,094.8 823.2 936.4 1,001.0 102.9 117.1 125.1 10% 19.0 16.7 15.6 27.9 24.0 19.3 16.5 20.7 1.1
BHEL 2,300.0 26,234.2 33,543.9 41,860.1 3,138.2 4,431.5 5,716.0 64.1 90.5 116.8 35% 35.9 25.4 19.7 41.7 47.7 27.4 28.1 15.3 0.7
Bharti Airtel 298.0 36,961.5 40,635.7 42,803.7 8,469.9 9,157.1 8,673.6 22.3 24.1 22.8 1% 13.4 12.4 13.1 22.1 17.3 25.0 20.1 0.0 0.0
Corp Bank 428.0 2,798.2 3,276.3 3,822.6 892.7 1,068.8 1,187.4 62.2 74.5 82.8 15% 6.9 5.7 5.2 - - 20.1 19.2 12.5 2.9
Crompton Greaves 415.0 8,737.3 9,472.3 10,681.6 562.5 809.2 910.8 15.3 22.1 24.8 27% 27.0 18.8 16.7 42.5 40.6 32.2 27.7 2.0 0.5
Glenmark Pharma 253.0 2,116.0 2,454.8 2,929.1 312.2 340.2 449.4 12.5 12.5 16.5 15% 20.2 20.2 15.3 13.3 15.0 13.7 15.5 0.4 0.2
Godrej Consumer*** 250.0 1,393.0 2,119.5 2,484.5 173.3 341.7 414.2 6.7 11.1 13.4 41% 37.3 22.5 18.7 36.6 34.8 43.8 39.8 4.0 1.6
Grasim 2,565.0 10,804.0 12,427.7 12,660.5 1,648.0 2,426.7 2,111.4 179.8 264.7 230.3 13% 14.3 9.7 11.1 16.5 13.0 20.4 15.5 30.0 1.2
HCL Tech** 338.0 10,591.0 12,639.2 14,214.6 1,200.9 1,226.7 1,610.4 17.9 18.1 23.6 15% 18.9 18.6 14.3 33.2 38.0 21.7 24.4 9.0 2.7
HUL* 228.8 20,239.3 17,520.6 19,716.4 2,391.4 2,240.0 2,559.7 8.8 10.3 11.8 16% 26.0 22.2 19.4 124.0 111.5 98.9 95.6 7.5 3.3
ICICI Bank 796.0 15,970.3 15,873.6 18,040.4 3,758.1 4,122.7 5,265.5 33.8 37.0 47.3 18% 23.6 21.5 16.8 - - 8.1 9.8 11.0 1.4
Indian Hotel Co 87.3 2,686.1 2,705.2 3,281.7 12.5 195.7 287.5 0.6 2.7 4.0 158% 145.5 32.3 21.8 5.6 9.8 4.6 9.3 1.2 1.4
ITC 248.0 15,582.7 17,705.5 20,383.1 3,263.6 4,080.1 4,789.4 8.6 10.8 12.6 21% 28.8 23.0 19.7 36.6 36.7 27.2 27.0 3.7 1.5
Lupin 1,545.0 3,775.9 4,830.1 5,798.9 533.8 683.9 844.3 64.4 76.3 94.2 21% 24.0 20.2 16.4 24.9 25.7 29.0 27.4 12.5 0.8
M&M 972.0 13,094.1 17,895.0 21,336.0 772.9 1,918.1 2,148.4 30.6 68.5 76.8 58% 31.8 14.2 12.7 28.0 27.3 28.2 25.1 10.0 1.0
Marico 97.6 2,388.4 2,670.4 3,050.5 209.1 253.5 304.0 3.4 4.2 5.0 21% 28.7 23.2 19.5 41.0 42.3 46.0 39.1 0.7 0.7
Maruti Suzuki 1,352.0 20,455.4 28,099.0 31,967.0 1,202.0 2,491.0 2,725.0 41.6 86.2 94.3 51% 32.5 15.7 14.3 32.5 29.1 23.7 21.1 3.5 0.3
Nicholas Piramal 360.5 3,281.1 3,763.4 4,431.4 360.9 463.9 549.4 17.3 22.2 26.3 23% 20.8 16.2 13.7 19.5 22.7 27.9 26.4 4.2 1.2
Punj Lloyd 176.3 11,912.0 12,325.7 15,410.6 (216.3) 340.9 470.5 - 10.3 14.2 - - 17.2 12.4 13.7 13.8 12.1 14.4 0.3 0.2
SBI 1,897.5 33,563.9 38,158.8 45,870.5 9,121.2 10,210.8 11,634.8 143.7 160.8 183.3 13% 13.2 11.8 10.4 - - 16.5 16.6 29.0 1.5
Sintex Industries 248.9 3,063.9 3,239.7 3,710.7 329.8 318.8 384.2 24.3 23.5 28.4 8% 10.2 10.6 8.8 11.8 13.9 15.9 16.3 1.0 0.4
Tata Tea 932.3 4,874.1 5,759.7 6,655.5 338.4 388.0 444.7 54.9 62.8 71.9 14% 17.0 14.8 13.0 8.2 9.6 10.0 10.3 17.5 1.9
Wipro 642.0 25,699.6 27,526.4 30,959.3 3,899.9 4,683.8 5,340.7 26.6 32.0 36.4 17% 24.1 20.1 17.6 24.7 23.7 25.8 22.8 4.0 0.6
Emerging Star
3i Infotech 79.5 2,285.6 2,461.7 2,741.4 248.6 236.2 283.4 15.5 12.0 14.3 -4% 5.1 6.6 5.6 10.7 10.3 10.2 9.9 1.5 1.9
Allied Digital 211.9 552.1 693.7 808.6 74.5 104.2 125.0 20.6 22.2 26.6 14% 10.3 9.5 8.0 22.0 19.4 21.3 17.2 1.0 0.5
Alphageo India 196.8 63.9 90.0 100.0 6.0 12.5 12.9 11.6 24.3 25.2 47% 17.0 8.1 7.8 40.0 39.2 20.6 17.6 1.5 0.8
Axis Bank 1,037.0 6,583.1 9,030.7 10,411.1 1,815.4 2,543.9 3,084.1 50.6 63.2 76.6 23% 20.5 16.4 13.5 - - 18.5 17.9 10.0 1.0
Balrampur Chini 117.0 1,753.2 2,399.0 2,570.7 202.7 357.4 402.5 7.9 13.9 15.7 41% 14.8 8.4 7.5 22.8 23.6 28.1 25.1 3.0 2.6
Cadila Healthcare 677.5 2,927.5 3,744.1 4,309.0 327.3 484.7 578.3 24.0 35.5 42.4 33% 28.2 19.1 16.0 22.0 23.3 27.4 27.2 4.5 0.7
EMCO 88.5 996.3 1,144.0 1,363.6 58.5 61.6 81.9 9.9 10.5 12.6 12% 8.9 8.5 7.0 15.6 17.3 12.9 14.1 1.4 1.6
Greaves Cotton 273.0 1,037.1 1,222.3 1,506.1 56.0 107.6 139.6 11.2 22.0 28.6 60% 24.4 12.4 9.5 34.4 37.5 24.3 26.7 4.0 1.5
Max India 202.0 4,854.2 - - (306.7) - - -10.5 - - - -19.2 - - - - - - - -
*FY2009 is of 15 months ending March 2009 as company has changed reporting year from CY to FY **June ending company
#September ending company @Stand-alone financials
***RoE and RoCE are on stand-alone basis due to non availiability of consolidated balance sheet post recent acquisitions.
SEAMEC^^ 200.5 268.6 456.0 247.5 88.2 283.2 81.8 26.0 83.5 24.1 -4% 7.7 2.4 8.3 63.2 13.4 46.4 12.2 0.0 -
Subros 43.9 694.4 889.2 1,055.7 13.9 26.7 34.9 2.2 4.4 5.8 62% 20.0 10.0 7.6 16.0 17.9 12.5 13.8 0.5 1.1
Sun Pharma 1,460.0 4,272.3 4,023.1 4,525.6 1,817.7 1,379.3 1,444.1 87.8 66.6 69.7 -11% 16.6 21.9 20.9 16.5 15.6 17.0 15.7 13.8 0.9
Torrent Pharma 466.5 1,630.7 1,929.5 2,176.5 234.3 250.2 334.5 27.7 29.6 39.5 19% 16.8 15.8 11.8 30.5 29.0 32.6 32.5 4.0 0.9
UltraTech Cement 930.0 6,383.1 7,120.7 7,019.2 977.0 1,106.6 826.1 78.5 88.9 66.4 -8% 11.8 10.5 14.0 29.6 20.8 24.0 15.4 5.0 0.5
Union Bank of India 240.0 5,296.1 6,210.6 7,623.7 1,726.6 1,926.7 2,302.3 34.2 38.1 45.6 15% 7.0 6.3 5.3 - - 24.2 23.5 5.0 2.1
United Phosphorus 153.6 4,931.7 5,415.6 6,248.0 472.7 536.5 707.4 11.0 11.7 16.6 23% 14.0 13.1 9.3 14.3 17.7 17.1 20.2 1.5 1.0
Zensar Tech 288.0 908.1 998.3 1,115.4 86.5 126.7 137.5 36.0 58.6 63.7 33% 8.0 4.9 4.5 34.5 29.4 35.6 28.2 3.8 1.3
Vulture’s Pick
Esab India^ 555.0 423.6 420.0 468.9 61.2 65.6 73.7 39.7 42.6 47.8 10% 14.0 13.0 11.6 64.7 58.2 37.9 34.5 15.5 2.8
Mahindra Lifespace 375.0 341.8 598.2 789.0 65.7 134.5 171.2 16.1 32.9 41.9 62% 23.3 11.4 8.9 14.6 16.1 13.4 14.8 2.5 0.7
Orient Paper 44.7 1,503.2 1,578.4 1,858.1 231.5 153.8 189.7 12.1 8.0 9.9 -9% 3.7 5.6 4.5 22.6 25.8 20.2 20.7 1.5 3.4
Tata Chemicals 284.7 12,257.7 9,637.5 10,714.4 1,051.8 715.8 800.3 43.2 29.4 32.8 -13% 6.6 9.7 8.7 13.4 14.1 13.4 13.7 9.0 3.2
Unity Infraprojects 560.0 1,130.8 1,481.5 1,933.5 69.7 84.4 105.3 52.1 57.0 71.1 17% 10.7 9.8 7.9 17.7 18.9 17.1 17.1 4.0 0.7
Cannonball
Allahabad Bank 132.1 3,300.6 3,963.7 4,776.4 768.6 1,222.4 1,299.4 17.2 27.4 29.1 30% 7.7 4.8 4.5 - - 20.5 19.6 3.0 2.3
Andhra Bank 97.2 2,392.3 3,223.2 3,831.5 653.0 1,056.5 1,218.5 13.5 21.8 25.1 36% 7.2 4.5 3.9 - - 26.5 25.8 4.5 4.6
Dhampur sugar 121.0 948.0 1,936.4 1,807.5 56.8 230.5 171.5 10.6 42.7 31.8 73% 11.4 2.8 3.8 24.8 19.8 38.6 22.2 1.5 1.2
IDBI Bank 115.0 2,715.8 4,647.3 5,773.7 858.5 1,110.2 1,374.3 11.8 15.3 19.0 27% 9.7 7.5 6.1 - - 13.7 14.7 2.5 2.2
Phillips Carbon 178.9 1,163.3 1,409.8 1,643.4 (64.8) 118.5 126.4 -24.1 42.0 44.7 - -7.4 4.3 4.0 28.0 27.0 35.3 27.3 0.0 -
Madras Cements 105.0 2,530.4 2,905.7 2,911.7 363.5 361.5 292.1 15.3 15.2 12.3 -10% 6.9 6.9 8.6 16.8 13.7 23.1 16.3 2.0 1.9
Shree Cement 2,000.0 2,715.0 3,613.1 3,914.9 602.7 926.6 667.3 173.0 266.0 191.5 5% 11.6 7.5 10.4 39.3 24.6 44.6 24.8 10.0 0.5
TFCI 25.9 42.7 47.7 58.5 25.3 24.9 32.0 3.1 3.1 4.0 14% 8.4 8.4 6.5 - - 8.5 10.4 1.0 3.9
^Year CY instead of FY # September ending company
^^Year FY instead of CY
Evergreen
HDFC HDFC provides housing loans to individuals, corporates and developers. It has interests in banking, asset
management and insurance through its key subsidiaries. Three of these—HDFC Bank, HDFC Life Insurance and
HDFC Mutual Fund—are valued at Rs941 per share of HDFC. As these subsidiaries are growing faster than HDFC,
the value contributed by them would be significantly higher going forward.
HDFC Bank HDFC Bank has merged Centurion Bank of Punjab with itself and the reported numbers for FY2009 represent the
financials of the merged entity. Relatively high margins (compared with its peers), strong branch network and better
asset quality make HDFC Bank a safe bet.
Infosys Tech Infosys is India's premier IT and IT-enabled service company. It is one of the key beneficiaries of the strong trend of
offshore outsourcing. It is relatively better positioned to weather the tough business environment and also among
major beneficiaries of the revival in IT spending.
L&T Larsen & Toubro, being the largest engineering and construction company in India, is a direct beneficiary of the strong
domestic infrastructure boom. Strong potential from its international business, its sound execution track record,
bulging order book and strong performance of subsidiaries further reinforce our faith in it. There also lies great growth
potential in some of its new initiatives.
Reliance Ind RIL holds great promise in E&P business with the start of gas production from KG basin in April 2009 and that of
crude oil in September 2008. We expect the GRM to remain low due to narrowing down of light-heavy crude price
differential and declining middle distillate crack spread. However, RIL is likely to fetch premium over Singapore
Complex’ GRM due to its superior refinery complexity. Petrochem margins of the company have improved with the
uptake in the domestic demand and higher price realisation in the domestic market. We expect these levels of petrochem
margins to sustain in the medium term.
TCS TCS pioneered the IT services outsourcing business from India and is the largest IT service firm in the country. It is
a leader in most service offerings and is in the process of further consolidating its leadership position through the
inorganic route and large deals.
Apple Green
Aditya Birla Nuvo We believe the value businesses of the company (insulators, textiles, fertilisers, carbon black and rayon) have started
witnessing increased efficiency as reflected in sharp improvement in their operating margins, while the growth
businesses (retail, BPO, life insurance and financial services) are showing improved revenue visibility and gaining
strong market share. We believe strong internal cash flows from value businesses coupled with promoter funding
coming in would meet the funding requirement of the growth businesses.
Apollo Tyres Apollo Tyres is the market leader in truck and bus tyre segments with a 28% market share. Strong demand in OEM
as well as replacement segment coupled with a lower raw material cost on a year-on-year basis will lead to a three-
fold jump in its FY2010 net profit. In the long term, the company is likely to benefit from acquisitions made in overseas
markets and capacity expansion in domestic business.
Bajaj Auto Bajaj Auto is a leading two-wheeler automobile company. It is moving up the value chain by concentrating on the
executive and premium motorcycle segments. The success of the new launches will drive most of the growth for the
company during the year and help the company to regain its lost market share in the 125cc+ segment.
Bajaj Finserv Bajaj Finserv is the only pure insurance play available in the market currently. It is one of the top three players in the
fast growing life insurance segment and also has a sizable presence in the general insurance segment.
Bajaj Holdings Bajaj Holdings is the holding company of the Bajaj group, having a 30% stake each in Bajaj Auto and Bajaj Finserv.
The two-wheeler sales are expected to improve going forward with new product launches. The insurance business
makes it one of the largest players in the insurance space.
Bank of Baroda With a wide network of over 2,900 branches across the country, BoB has a stronghold in the western and eastern parts
of India. The bank has laid out aggressive plans to grow supplementary businesses including insurance and on-line
broking, which should boost its fee income. We expect its earnings to post a CAGR of 19% over FY2009-11E.
Bank of India BoI has a wide network of branches across the country and abroad along with a diversified product & services
portfolio, as well as steady asset growth. However the sharp deterioration in asset quality may pose some concerns
going ahead. As a result we have downgraded our recommendation on the stock to reduce.
Bharti Airtel Bharti Airtel is leading the wireless telephony revolution and has emerged as the largest mobile operator in the country.
The company maintains its strong subscriber addition, however with the intensifying tariff war the ARPU has come
under pressure. The company maintains its market leadership and remains our top pick in the sector.
BEL BEL, a public sector unit that manufactures electronic, communication and defence equipment, is benefiting from
enhanced capital expenditure outlay under the Union Budget to strengthen and modernise country’s security system.
The overall growth in the company’s revenues is also expected to be aided by civilian and export orders. We are positive
on BEL’s full-year estimates and long-term prospects.
BHEL India's biggest power equipment manufacturer will be the prime beneficiary of the four-fold increase in the investments
being made in the domestic power sector. The current order book of Rs1,34,000 crore stands at around 4.8x its
FY2009 revenues and we expect the company to maintain the strong growth momentum.
Corp Bank Corporation Bank has one of the highest Tier-I CAR among its peers. This leaves ample scope for the bank to leverage
the balance sheet without diluting the equity, quite unlike the other state-owned banks. The bank is most aggressive
on technology implementation with all its branches under Core Banking Solution, covering 100% business of the
bank, giving it a competitive edge over its peers.
Crompton Greaves TThe outlook for Crompton Greaves' key businesses of industrial and power systems is buoyant. A consolidated
order book of close to Rs6,200 crore generates clear earnings visibility. The synergy from the acquisition of Pauwels,
GTV and Microsol will drive the company’s consolidated earnings.
Glenmark Pharma Through the successful development and out-licensing of three molecules in a short span of six years, Glenmark has
become India's best play on research-led innovation. It has built a pipeline of 13 molecules and has managed to clinch
four out-licensing deals worth $734 million. Its core business has seen stupendous success due to its focus on niche
specialties and brand building. Out-licensing deals of its key molecules would provide further impetus to the earnings.
GCPL Godrej Consumer Products Ltd (GCPL) is a major player in toilet soap, hair colour and liquid detergent segments.
The recent acquisition of 49% stake in Godrej Sara Lee has expanded the company’s product portfolio to aerosols
and household insecticides and has improved the growth prospects and business model tremendously. While we
expect good sales growth to sustain on the back of gains in the market share, benign raw material cost will further
aid strong growth in the bottom line. Also likely acquisitions in the near term could act as trigger for the stock.
Grasim Post restructuring of its cement business Grasim would become a holding company for cement business and would be
left with just VSF and chemical division. At consolidated level the move will not result in any material change in earnings
estimates. On the other hand due to revival in demand for VSF, Grasim is planning to add another 80,000 tonne capacity
by FY2013 with an investment of Rs1,000 crore.
HCL Tech HCL Tech is one of the leading Indian IT service vendors. It has outperformed its peers in terms of better financial
performance in the past few quarters on the back of ramp up in business from large deals bagged earlier. However,
we see risk to the company’s earnings due to upfront free transition cost on the recent deals, margin dilution from
Axon acquisition and huge unrecognised forex loss sitting on its balance sheet.
HUL HUL is India's largest fast moving consumer good (FMCG) company. With sales volumes and market share under
severe pressure the company has shifted its focus from profitability to regain volumes. The company has implemented
corrective measures, which will improve the volumes in the coming quarters. In the long term HUL will be one of the
key beneficiaries of the Indian consumerism story.
ICICI Bank ICICI Bank is India's second largest bank. With strong positioning in retail segment, it enjoys healthy growth in both
loans and fee income. However, deteriorating asset quality is a cause for concern. Its various subsidiaries add ~Rs177
to the overall valuation. Moreover, the bank offers substantial value unlocking opportunities with the expected listing
of its subsidiaries like ICICI Securities and ICICI Prudential Life Insurance.
Indian Hotels Co Indian Hotels is the largest hotelier in India with a vast portfolio of hotel properties around the globe. Over the long term
the company would benefit from increase in tourism and corporate travels in India. Also, a turnaround in profitability
of its overseas properties would boost its earnings. The occupancies in the domestic business have revived as the macro
economic environment has improved. This will be followed by increase in room rates going ahead, which augurs well
for the company.
ITC ITC has a strategy of effectively utilising the excess cash generated from its cash cow, the cigarette business, to
strengthen and enhance it’s other non-cigarette businesses. This would nurture the growth of these businesses some
of which are at nascent stage. As ITC gains leadership position in each of these businesses, we expect its valuations
to improve further, reducing the gap between its valuation and that of HUL.
Lupin The leading pharma company is set to take off in the export market by targeting the US market (primarily for
branded formulations) while maintaining its dominance in the anti-TB segment globally. Further, with an expanded
field force and therapy focused marketing division, its branded formulation business in the domestic market has
been performing better than the industry. Its ongoing R&D activities are also expected to yield sweet fruits going
forward.
M&M M&M is a leading maker of tractors and utility vehicles in India. New product launches are likely to drive its growth
going forward in the automobile segment, while the company has consolidated well in the tractor segment with the
acquisition of Punjab Tractors. Further, its investments with world majors in passenger cars and commercial vehicles
have helped it diversify into various automobile segments, while the value of its subsidiaries adds to its sum-of-the-
parts valuation.
Marico Marico is India's leading FMCG company. Its core brands, Parachute and Saffola, have a strong footing in the market.
It intends to play on the broader beauty and health platform. It follows a three-pronged strategy that shall ensure
its growth in the long term. The strategy hinges on expansion of existing brands, launch of new product categories
and growth through acquisitions. Thus while Marico has entered new categories like health foods and Kaya clinics,
it has also expanded its presence in markets such as UAE and South Africa through acquisitions.
Maruti Suzuki Maruti Suzuki is India's largest small car maker. The company is the only pure passenger car play in the domestic market
and has been outperforming the industry consistently. With new launches and strong existing product basket, the
company continues to outperform the market growth rate. Suzuki has identified India as a manufacturing hub for small
cars for its worldwide markets.
Piramal Health The pharma major is ready to gain from the ramp-up in its contract manufacturing deals with MNCs. Further, the
acquisition of Minrad would boost its critical care business segment. However, a subdued CRAMS outlook and
pressure on margins on account of integration of Minrad could lead to risk of underperformance.
Punj Lloyd Punj Lloyd is the second largest EPC player in the country (the first being Larsen & Toubro) with a global presence.
In FY2007, PLL acquired SEC and Simon Carves, which helped it plug gaps in the services offered by it. The average
order size and execution capability of PLL has also increased significantly making it the only player capable of
competing with Larsen & Toubro. However, in recent times the profitability has come under severe pressure due to
cost overruns in some of its subsidiaries’ projects and rising working capital requirement.
SBI Despite being the largest bank of India, SBI is growing at a high rate which is commendable. Its loan growth is likely
to remain healthy at ~20% with improving core operating performance and stable net interest margins. Successful
merger of associate banks could provide further upside for the parent bank. The asset quality of the bank would remain
a key monitorable.
Sintex Industries A key player in the plastic specialties space, Sintex Industries has a diverse business model with presence in construction,
prefabs, custom molding and textiles business. Being a pioneer in monolithic construction technique, it is witnessing
strong traction in order inflow for this division. Given the need for affordable housing, we expect its order book to
remain buyout in the future. Present in exciting growth businesses, its revenue and profits are expected to post CAGR
of 11.8% and 13.7% respectively over FY2009-12E.
Tata Tea Over the past two years, Tata Tea has transformed itself from just a commodity (tea) seller to a branded tea maker.
It has acquired management control of Mount Everest Mineral water, owner of the Himalayan brand and plans to
enter RTD beverage segment through launch of TION in the domestic market. This makes the company a complete
beverage company having presence in the entire vertical: tea, coffee, Fruit drinks and water. However its valuation
is much cheaper than that of its peers.
Wipro Wipro is one of the leading Indian IT service companies. The company has shown strong performance in recent
quarters. However, Wipro’s key user industries (telecom OEM and technology) remains muted due to change in the
management at client level and reduction in discretionary spending. But its performance is likely to improve in coming
quarters.
Emerging Star
3i Infotech 3i Infotech offers software products and solutions to the BFSI sector. The growth momentum is expected to continue
due to a healthy order book. Moreover, the recent fund-raising exercise has allayed concerns related to relatively-high
financial leverage on its balance sheet.
Allied Digital The company is a leading player in the fast-growing remote infrastructure management service. It is believed to be
close to signing a pact with one of the leading PC server manufacturers to offer its services as bundled offering to its
OEM clientele. This coupled with a sustainable margin will cause its earnings to grow at a CAGR of over 29.6% during
FY2009-11.
Alphageo Alphageo provides seismic survey and other related support services to oil exploration & production companies in
India. The recent order wins and a healthy pipeline of orders have considerably improved the company's revenue
growth visibility.
Axis Bank Over the last few years, Axis Bank (UTI Bank) has grown its balance sheet aggressively. Notably, the bank has
maintained a delicate balance between aggressive balance sheet growth and profitability. Besides the core banking
business, the bank plans to foray into asset management business under a joint venture with Banque Privee. We expect
the quality of its earnings to improve as the proportion of fee income goes up.
Balrampur Chini Balrampur Chini is the second largest sugar producer in the country and has an integrated business model with
distillery and power co-generation facilities. The Indian sugar cycle is witnessing a strong uptrend with production
deficit leading to a sharp jump in sugar prices. We expect Balrampur Chini’s profits to grow at a hefty CAGR of 41%
over FY2008-11 driven by sugar prices.
Cadila Cadila's improving performance in the US generic and French market, along with the steady progress in the CRAMS
space, enriches its growth visibility. With key subsidiaries turning profitable, Cadila is all set to harvest the fruits of
its long-term investments.
EMCO A leading player in the transformer space Emco is also fast emerging as an end-to-end player in the power T&D space.
The company has a strong order book of Rs1,500 crore. Furthermore, its new business initiatives (coal mining) could
be value accretive in the future.
Greaves Cotton Greaves Cotton is a midsize and well-diversified engineering company. The Company’s core competencies are in Diesel/
Petrol engines, Power Gensets, Agro engines & pumpsets (Engines segment) and Construction Equipment
(Infrastructure equipment segment). The engine business accounts for ~85% of the company’s revenue, while the rest
comes from infrastructure equipment. With strong growth in sales of automotive engines and expected revival in the
construction equipment sales we expect the company to post a robust CAGR of 60% in profits over FY2009-11.
Max India Max India is a unique investment opportunity providing direct exposure to two sunrise industries of insurance and
healthcare services. Max New York Life, its life insurance subsidiary, is among the leading private sector players, has
gained the critical mass and enjoys some of the best operating parameters in the industry. With insurance penetration
picking up in India and the company expanding its distribution network steadily, we expect to see a healthy growth
in the company’s APE going ahead.
Network 18 Network 18, the holding company of the TV18 group, owns the best media properties through its holdings in TV18
and IBN 18. While TV18 owns business channels CNBC and Awaaz, and Internet properties such as moneycontrol.com;
IBN 18 controls CNN-IBN and IBN-7. IBN 18’s Hindi GEC Colors is the no. 1 channel in the genre, via its tie-up
with Viacom. It also operates a home shopping network inclusive of a dedicated home shopping channel. We expect
Network 18 to create value through its holdings.
Opto Circuits A leading player in manufacturing medical equipment like sensors and patient monitors, Opto has diversified into
the invasive space where it supplies stents for medical use. Lower cost base and attractive pricing strategies have enabled
Opto's stents to gain acceptance globally. Steady growth in the non-invasive segment and increasing acceptance of
DIOR, a revolutionary cardiac balloon, in Europe would drive Opto's growth. Further, Criticare acquisition will
enable Opto to diversify into gas monitoring systems and strengthen its position in the USA.
Patels Airtemp Patels Airtemp, a manufacturer of heat transfer technology products, would benefit immensely from the strong boom
in its user industries, particularly oil and gas, refineries and power. It currently has a strong order book of Rs50 crore
while the order inflow is expected to remain steady in the next two years too.
Thermax The company’s energy and environment businesses are set to benefit from the continuing rise in India Inc's capex.
Its order book stands at Rs5,612 crore, which is 1.7x its FY2009 consolidated revenues. We are positive on its possible
entry into super-critical boilers and its robust order inflow outlook from the power sector.
Zydus Wellness Zydus Wellness owns three high growth brands, Nutralite, Sugar free and Ever Yuth in the niche health and wellness
segment. The company focuses on rampant growth by increasing the distribution of existing products, scaling up
the existing product portfolio through variants and new product launches leveraging the three brands. Also, the tax
benefit from the new facility would aid in a strong bottom line growth in the coming years. Thus, we expect the
company’s profit to register a strong CAGR of 50% over FY2009-12E.
Ugly Duckling
BASF India BASF India is set to benefit from the changing demographics and the resulting consumption boom in India. The company
is building a 9,000TPA engineering plastics compounding plant at its existing Thane facility. The company is likely to
benefit from the new capacity addition that would help it cater to the demand from user industries like automobile,
construction, white goods, home furnishing and paper.
Deepak Fert DFPCL manufactures and supplies industrial chemicals and ANP fertilisers. With the chemical prices stabilising, the
revenue and margin of the company is expected to expand in the future. Its new technical ammonium nitrate (TAN)
plant is on schedule and expected to commence operations by November 2010. We believe, this will contribute
significantly to the company’s top line as well as bottom line going forward.
India Cements On the back of a modified capex plan, India Cements has joined the league of top five cement players with a capacity
of 14MMT at the end of June 2009 and that of 16MMT by FY2010. The capacity addition will lead to volume growth
and drive the earnings. The company is also setting up a 100MW captive power plant, which is expected to come on-
stream by March 2011. However, we expect the OPM and profitability to contract in FY2011 due to severe pressure
on cement realisation in southern India.
Ipca Lab A well-known name in the domestic formulation space, Ipca has successfully capitalised on its inherent strength in
producing low-cost APIs to tap export markets. The company's ongoing efforts in the branded promotional business
in emerging economies, revival in the UK operations, pan-European initiatives and a significant scale-up in the US
business will drive its formulation exports.
ISMT A leading maker of seamless tubes in India, ISMT is likely to benefit from improving demand in its traditional user
industries like automobile and mining. It would also gain from efforts taken to expand its product offerings and
increasing the size of addressable market by penetrating into energy and oil exploration sectors. It is also set to gain
from lower power cost with its captive power plant coming into operations in H2FY2011. We expect the profit to
grow at a CAGR of 50% over FY10E-12E.
Jaiprakash Asso Jaiprakash Associates, India's leading cement and construction company, is all set to reap the benefits of India's
infrastructure spending. The company has also monetised very well on the real estate properties of Yamuna
Expressway. Moreover, the marked improvement in macro environment has improved accessibility to capital and
thus eased the concerns of liquidity to some extent. However, higher leverage could act as drag on the valuation.
Mold Tek Tech Mold-Tek Technologies is aggressively scaling up the knowledge process outsourcing business. The company is also
likely to expand into the infrastructure vertical apart from high-rise building verticals.
Orbit Corp Given its unique business model, Orbit is expected to cash in the massive re-development opportunities in southern and
central Mumbai. The company has shown marked pick-up in volume in the recent past. Further, it plans to launch atleast
one project every quarter which would ensure steady cash flow going ahead.
PNB PNB has one of the best deposit mixes in the banking space with low-cost deposits constituting around 39% of its
total deposits. A strong liability franchise and technology focus will help the bank boost its core lending operations
and fee income related businesses.
Pratibha Ind Pratibha Industries is a dominant player in the water & irrigation and urban infrastructure segments. The backward
integration into manufacturing of HSAW pipes has enabled it to bid for pipeline related projects at very competitive
prices. It has also diversified into other high-margin areas like power and oil & gas and has an order book of Rs3,500
crore which is 4x its FY2009 revenues. With the government giving huge impetus on these segments, we expect the
PAT to post a CAGR of 33% over FY2009-12.
Ratnamani Metals Ratnamani Metals and Tubes is the largest stainless steel tubes and pipes maker in India. Inspite of the challenging
business environment due to increasing competition, we believe the stock is attractively valued at a discount of ~40%
to the average of large pipe players due to lower scale of operations. We believe with the increasing order backlog of
the EPC contractors, the order inflow visibility is set to improve going forward.
Selan Exploration Selan is an oil exploration & production company with five oil fields in the oil rich Cambay Basin off Gujarat. The
initiatives taken to develop and monetise the oil reserves in its Bakrol and Lohar oil fields are likely to significantly
ramp up the production capacity and lead to re-rating of the stock.
SEAMEC With a fleet of four MSVs, SEAMEC is a key beneficiary of higher rates for MSVs on account of surge in oil exploration
spends. However, under utilisation of assets with two vessels going for dry-docking in 2010 would be a key issue.
Shiv-vani The company is the largest onshore oil exploration service provider in the domestic market. Its strong order book of
Rs3,700 crore, 4.2x its FY2009 revenues, provides great visibility to its earnings over the next three to four years. The
earnings are estimated to show a CAGR of 15.8% during FY2010-12E.
Subros Subros is the largest integrated manufacturer of automobile air conditioning systems in India. It is expected to be the
prime beneficiary of the buoyancy in the passenger car segment led by its key clients Maruti Suzuki, Tata Motors and
Mahindra & Mahindra.
Sun Pharma With stronghold in domestic formulation market, Sun Pharma has become an aggressive participant in the Para IV patent
challenge space. Having already garnered four exclusivity opportunities in the USA, any further news flow on Para IV
challenges and Taro acquisition would drive the stock. However, the recent FDA action on Caraco significantly
compounds the near-term growth outlook for the base US business.
Torrent Pharma A well-known name in the domestic formulation market, Torrent has been investing in expanding its international
presence. With the investment phase now over, Torrent should start gaining from its international operations in
Russia and Brazil. The impending turnaround of its German acquisition, Heumann, will also drive the profitability
of the company.
UltraTech Cement Post restructuring of cement business of Grasim, UltraTech will emerge as India’s largest cement company with ~49
million tonne cement capacity. Despite expectation of subdued cement prices in future, UltraTech’s OPM is expected
to improve in FY2010E. 4.9MTPA capacity expansion in Andhra Pradesh and savings accruing from new captive
power plants will improve the company’s cost efficiency.
United Phos A leading global producer of crop protection products, intermediates, specialty chemicals and other industrial
chemicals, United Phosphorus has presence across value-added agricultural inputs ranging from seeds to crop
protection products and post-harvest activities. We expect the bottom line to grow at a CAGR of 20.4% during
FY2009-12E. A diversified product portfolio, a strong distribution network and presence across geographies make
United Phosphorus a good investment play in the agro-chemical space.
UBI Union Bank has a strong branch network and an all-India presence. The net NPAs are below 1%, indicating strong
asset quality along with a healthy asset growth. With strong return ratios and stable performance in terms of various
operating parameters, the bank is a good investment play.
Zensar Zensar, promoted by the RPG group, has effectively utilised the inorganic route to gain critical mass in the fast growing
enterprise solutions segment and extend its presence in newer markets.
Vultures’s Pick
Esab India ESAB India is a leading manufacturer of electrodes and welding equipment. A change in the positioning of its products
from low-margin, high-volume products to quality and high-margin products would further boost its profitability.
Mahindra Lifespace The company owns Chennai SEZ, making it the only private sector player in the country to have an operational SEZ.
Leveraging its rich expertise, the company is planning to develop one more SEZ, in Jaipur. We also expect significant
improvement in the margins primarily due to higher revenue contribution from Chennai's non-processing area and
better realisation for Jaipur SEZ processing area. Consequently, we expect the company's net income to grow at a
CAGR of 51.7% over FY2009-12.
Orient Paper Orient Paper is in the process of increasing its capacity from 3.4 million tonne to 5 million tonne. The 50MW captive
power plant and cement plant at Devapur is delayed by a quarter and now expected to come on stream by Q4FY2010.
The new capacities are expected to drive the earnings of the company.
Tata Chemicals With a combined capacity of 5.5MMTPA Tata Chemicals is the second largest soda ash producer in the world. By
acquiring controlling stake in Rallis India, Tata Chemicals has increased its presence in the agri-business. The company
is all set to expand its agri-business portfolio with the introduction of specialty fertilisers and setting up a green field
urea plant. The regulatory changes in the fertiliser industry would also benefit the company.
Unity Infra With a well-diversified order book, Unity Infrastructure is expected to be the key beneficiary of the government's thrust
on infrastructure spending. Its order book remains strong at Rs3,770 crore, 3.3x its FY2009 revenues. We expect
its top line to post a CAGR of 26% on the back of a strong order book during FY2009-12. Further, it plans to enter
new segments like power and road BOT projects.
Cannonball
Allahabad Bank Allahabad Bank with a wide network of over 2,200 branches across the country has a strong hold in the northern and
eastern parts of India. With an average RoE of ~17% during FY2009-11E, the bank is available at an attractive valuation.
Andhra Bank Andhra Bank, with a wide network of over 1,200 branches across the country, has a strong presence in south India
specially in Andhra Pradesh. With an average RoE of ~19% during FY2009-11E, the bank is available at attractive
valuation.
Dhampur Sugar DSL is the fifth largest sugar producer in India with integrated facilities and it is going to be a key beneficiary of the current
upturn in the sugar cycle. We expect DSL’s profits to quadruple in FY2010 (end of September 2010) due to higher profits
from its sugar business led by higher sugar realisation and refining & sale of low-cost raw sugar.
IDBI Bank IDBI Bank is one of leading public sector banks of India. The bank is expected to improve its core performance significantly,
which is likely to reflect in the form of better margins and return ratios. Furthermore, the much-expected capital assistance
from the government would fuel business growth going forward. Moreover, a huge investment portfolio adds substantial
value to the bank.
Madras Cement Madras Cement, one of the most cost-efficient cement producers in India, will benefit from capacity addition carried
out by it ahead of its peers in the southern region. The 3 million tonne expansion will provide the much-needed volume
growth in the future. However, poor regional demand and much higher pressure on realisation due to upcoming
capacities will see the company post de-growth in FY2011 earnings estimates.
Phillips Carbon Phillips Carbon Black Ltd, a leading carbon black manufacturer in India, is one of the key beneficiaries of the revival
seen in the domestic tyre industry. The company also generates substantial revenue from the sale of surplus power
in the open market after meeting its captive demand. The surplus power sale is likely to be a major positive impact
on its earnings. Consequently, we expect the company to report significant improvement in its financial performance
over the next two years.
Shree Cement Shree Cement's 1-million-tonne seventh clinker line has come on stream in March 2009. The cement grinding capacity
of the company now stands at 9.1 million tonne and is expected to be 12MMT by the end of FY2010. Further more
the company is also setting up 300 MW of power plant entirely for the merchant sale and expected to come on stream
by FY2012. Thus, the volume growth in the cement division and additional revenue through sale of surplus power
capacity will drive the earnings of the company.
TFCI TFCI provides financial assistance to the hotel and tourism sector. As TFCI is exposed to only this sector, its
performance is inextricably linked to the prospects of this sector. This was largely responsible for TFCI's earlier
financial problems. However, things are now looking very promising for TFCI with improved asset quality and strong
loan demand due to significant expansion plans lined up by the hotel and tourism sector. We expect TFCI's earnings
to grow at a CAGR of over 14% over FY2009-11E.
A trend begins
I am sure it’s been a long wait and it should now pay off. The net asset value (NAV) of Nifty-Thrifty (NT)
has been flat for the last few months after the 15% drawdown seen in August last year and we have been
patiently waiting for the next 15%+ move in the index when it can make a meaningful difference to our
portfolios. The index has been in a small range and moved in single-day jumps. If the moves were slow
within a small range then too the system would have captured them but a less than 5% move with one to
two movements from one end to the other make it hard for the trend following systems to catch up. Starting
January 2010, for the first time it looks like the range of the market is starting to widen albeit on the down
side. With this I would expect clearer trends in the coming months which we can now profit from and see
NAV growth.
For more details or to open an account, contact our customer service department.
We will be more than delighted to answer all your queries regarding Sharekhan Portfolio Management Services.
A-206, Phoenix House, 2nd Floor, Senapati Bapat Marg, Lower Parel, Mumbai - 400 013.
Kollam
Sharekhan Branches
Pune - Nigdi Wardha
First Floor, A. Narayanan Shopping Complex, Kadappakada, ABC Plaza (Agarwal Complex), 2nd Flr, Plot No 6, Sector No Radhe Complex, 2nd Flr, Indira Mkt Road, Above Akola
Kollam - 691008. Tel: (0474) 2769120 to 25. 25, Bhel Chowk, Pradhikaran, Nigdi, Pune-44. Urban Bank, Wardha-442001. Tel: (07152) 645023 to 26.
Lucknow Tel: (020) 66300690-97. Mumbai - Andheri
2/159, Vivek Khand, Gomti Nagar, Lucknow - 226 010. B/204, Kotia Nirman, 2nd Floor, Next to Fun Republic
Tel: (0522) 4009832 to 33. Pondicherry
312/10, Vallar Salai,Vengata Nagar, Saram Revenue Village, Cinema,New Link Road, Andheri (W), Mumbai - 400 053.
Lucknow - Hazratganj Tel: 6675 0755 / 6675 0758 / 6675 0760 / 6675 0763.
Pondicherry - 605001. Tel: (0413) 4304904 to 09.
1st Floor, Marie Gold, 4,Shahnajaf Road, Hazaratganj,
Lucknow-226 001. Tel: (0522) 4010342,4010343. Raipur Mumbai - Borivali
"Ridhi House", 27/218, New Shanti Nagar, Raipur Shankar Ashish Bldg, 1st Floor, R.S.Marg, Chandavarkar
Lucknow - Rajajipuram
(Chattisgarh)-492007. Tel: (0771) 4217777, 4281172, Cross Road lane, Near ICICI Bank,Borivali (W), Mumbai-
Neeru Enclave, Jal Sansthan Crossing, CP, 7/201, Sector - 7, 400 092. Tel: (022) 65131221/65131222.
Raja Ji Puram, Lucknow - 226017. Tel: (0522) 2418996 /97. 4001004.
Ludhiana Rajkot Mumbai - Bhayander
SCO 145 1st Flr Feroze Gandhi Market, Near Ludhiana Stock 102/103, Hem Arcade, Opp Vivekanand Statue, Dr Yagnik Road, Shop No.20 & 21, Walchand Complex, Opp. Porwal School,
Exchange, Ludhiana -141001. Tel: (0161) 6547349 / 459 /469. Rajkot-360001 Tel: (0281) 2482483/84/85. Bhayander (W),Mumbai- 101. Tel: (022 ) 2804 1083/84/85
Madurai Rohtak Mumbai - Ghatkopar
Saran Centre, A-2, 1st Floor, 19, Gokhale Road, Ashoka Plaza, 1st Floor, Above ICICI Bank, Delhi Road, Rohtak - 202, Sai Plaza, 2nd Floor, Junction of Jawahar Road &
Chinnachokikulam, Madurai-625 002. Tel: (0452) 4288888. 124001. Tel - 09017058383. R. B. Mehta Marg, Ghatkopar (E), Mumbai 400 077.
Mangalore Tel: (022) 2510 8844 / 2510 8833.
C-1, 1st Floor, Presidium Commercial Complex, Anand Shetty Salem
Circle, Attavar, Mangalore - 575001. Tel: (0824) 6451503-4. Sri Ganesh Tower, 561, 2nd Floor, Saradha College Main Road, Mumbai - Goregaon
Salem - 636 007. Tel: (0427) 6454864 / 65/ 66. 301, 3rd floor, Plot No.343, Above ICICI Bank, S. V. Road,
Meerut
105, Om Plaza, Begum Bridge Road, Meerut-250001 (U.P.) Sangli Jawahar Nagar, Goregaon (West), Mumbai - 400 062.
Tel: (0121) 4028354/55. Tel (022) 67418570.
Ranjit's Empire, Office No-36,37,38, 2nd Floor, CS No.517 , Opp.
Mehsana Zillaparishad, Sangli-416416. Mumbai - Kandivali
14-15, 1st Floor, Prabhu Complex, Near Rajkamal Petrol Satara 10, Om Sai Ratna Rajul, Corner of Patel Nagar, M G Road,
Pump, Mehsana - 384002. Tel: (02762) 248980/249012. Kandivali (W), Mumbai-67. Tel: (022) 28090509/589.
First Floor, Shree Balaji Prestige, Powai Naka, Satara,
Mysore Maharashtra – 415001. Tel: (02162) 239824. Mumbai - Kandivali (Thakur Village)
Shop No.3, Mythri Arcade (Next to Saraswathi Theatre), Shop No 37, EMP-6, Jupitar CHS Ltd,Evershine Milleniam
Kantharaj Urs Road, Chamaraja Mohalla, Saraswati Puram, Siliguri
Mysore-570 009. Tel: (0821) 6451601 / 6451602 2nd Floor, Ganeshayan Bldg,112,Sevoke Road, Beside Paradise, Thakur Village, Kandivali (E), Mumbai- 400 101.
Nadiad Sunflower Shopping Mall, Siliguri-734001. Mumbai - Khar
201/202, City Point Complex, Near Parash Cinema,Santram Tel: (0353) 6453475 -79. 703, Prem Sagar Building , 1st Flr, 3 A Linking Road, Khar
Road, Nadiad - 387001. Tel: (0268) 2550555. Secunderabad (W), Mumbai - 400 052 Tel: (022) 65135333, 65133972-76.
Nagpur (C A) Marrideep Bldg, 1st Floor, 12-5-4, Vijayapuri, Mumbai - Lower Parel
409/412, Heera Plaza, Near Telephone Exchange Square, Opp St Annes College, Tarnaka, Secunderabad-500 017. "C" Phoenix House, 4th Floor, Senapati Bapat Marg,
Central Avenue, Nagpur-440 008. Tel: (0712) 2731922/23. Tel: (040) 64533871 to 75. Lower Parel, Mumbai-400 013. Tel: (022) 6618 9300.
Nagpur - Dharampeth
Plot No. 79, 1st Floor, Universal Annex, Dharampeth Surat Mumbai - Malad
Extension, Opposite New Wockhardt Hospital, Shivaji Nagar, M-1 to 6,Jolly Plaza, Mezzanine Floor, Athwa Gate, 502, Rishikesh Apartment, Opp to N L High School,
Nagpur – 440010. Tel: (0712) 6610752 to 58. Surat - 395 001. Tel: (0261) 6560310 to 6560314. S.V.Road, Malad (W), Mumbai- 64. Tel: (022) 6513 3969.
Navsari Surat - Advisory Mumbai - Matunga
1-Nirmal Complex, 1st Floor, Station Road, Sayaji Road, 419, Jolly Plaza, Athwagate, Surat-1. Tel: (0261) 6646841-45. Flat No 4B, Gr. Floor, Ashwin Villa, Telang Road, Matunga
Navsari - 396 445. Tel: (02637) 652300/652400/248888. (E), Mumbai - 400019. Tel: (022) 6513 9230/31/32
Thrissur
Nashik - College Road Pooma Complex, M G Road, Thrissur-1. Tel: (0487) 2446971-73.
5 SK Open Mall, Yeolekar Mala, Near BYK College, Mumbai - Mulund
College Road, Nashik-422 005. Tel: (0253) 6610975 to 978. Trichy - Cantonment Shop No. 1, Hetal Building, Gr Flr, Opp.Punjab National Bank,
Nashik Road F-1, Achyuta, 111-Bharatidasan Salai, Cantonment, Trichy- Zaver Road, Mulund (West), Mumbai -80.
1 st floor, Pratik Arcade, Bytco Point.Opp MSEB Office, 620001 (Tamilnadu). Tel: (0431) 4000705 / 2412810 Tel: (022) 2565 6805-10.
Nashik-Pune Road, Nashik Road, Maharashtra - 422 101. Tirupur Shop No. 2, New Krishna Dham, Veena Nagar, L.B.S.
New Delhi - Bharakhamba Road Ram Arcade, No 27, Muncif Court Street, Marg, Mulund (West), Mumbai - 400080.
903 & 903A, Kanchenjunga Bldg., 18-Bharakhamba Road, Tirupur- 641 601. Tel: (0421) 6454316 to 20. Tel: (022) 4024 1501-6
New Delhi-110001. Trivandrum
New Delhi - Pusa Road Mumbai - Opera House
Laxmi Bldg, 1st Floor, T.C.No.26/430, Vanrose Road, Gogate Mansion, Gr Floor, 89-Jagannath Shankar Seth
18/1 A, Ground Floor, Opposite City Hospital, Pusa Road, Trivandrum - 695 039. Tel: (0471) 6450657 / 58 / 59.
New Delhi -110005. Tel: (011) 45117000. Road, Girgaum, Opera House, Mumbai-4.
Udaipur Tel: (022) 6610 5671-75.
New Delhi - Lajpat Nagar
A95 B, II nd Floor, Lajpat Nagar –II, New Delhi - 110024. 17 C, Kutumb Apt, Opp. ICICI Bank, Madhuban, Udaipur-313001. Mumbai - Thane
Tel: (011) 46590373-376. Tel: (0294) 6454647 2nd Floor, Gulmohar Tower, Mahatma Phule Road,
New Delhi - Pitampura Vadodara Opp.A.K.Joshi High School. Naupada, Thane - 400 602.
411/412, Aagarwal Cyber Plaza, Netaji Subhash Place, 6-8/12, Sakar Complex, 1st Flr, Opp ABS Tower, Haribhakti Tel: (022) 2537 2158 to 61/ 2539 7778 - 9.
Pitampura, New Delhi - 110 034. Tel: (011) 47567000. Extension, Vadodara-390 015. Tel: (0265) 6649261-70. Mumbai - Stock Exchange (Rotunda)
New Delhi - Vasant Vihar Vadodara - Manjalpur 1st floor, Hamam House, Hamam Street, Fort, Mumbai
E-20, Basant Lok Community Center,Vasant Vihar, 1st Floor, Rutukalsh Complex, Tulsidham Char Rasta, 400 023. Mumbai-23. Tel: (022) 6610 5600 to 15
New Delhi -110057. Tel: (011) 26155086/7/9. Manjalpur, Vadodara - 390 011. Tel: (0265) 2647970-71.
New Delhi - Mayur Vihar Mumbai - Vashi
Shri Durga Ji shooping complex, Pocket II, Mayur Vihar, Vapi Persipolis Bldg., 108, 1st floor, Opp. St. Lawrence School,
Phase I New Delhi -110091. Tel: (011) 43067091- 96. Royal Fortune, D-101, E-101, 1st Floor, Vapi-Daman Road, Sector-17, Navi Mumbai-400703. Tel: (022)27882979-82.
New Delhi - Rajouri Garden Vapi - 396 191. Tel: (0260) 6452931 to 36
Mumbai - Vile Parle
A - 29, 2nd Floor, Ring Road, Rajouri Garden, Varachha - Surat 7-Alka CHS, Ground Floor, Dadabhai Road, Vile Parle (W),
New Delhi - 110027. Tel: (011) 45608923 to 27. G-20/21, Rajhans Point, Varachha Main Road, Varachha Road, Mumbai - 400056. Tel: (022) 26253010/11/12/13
Noida Surat-395006. Tel: (0261) 6453499.
P-12A, 3rd Floor, BHS Liberty, Sector-18, Noida - 201 301. Varanasi PCG Branch
Tel: (0120) 4646200. 2nd Floor, Banaras TVS Bldg., D-58/12, A-7, Sigra,
Palakkad Varanasi - 221 010 (UP). Tel: 0542 - 222 1073 / 81 / 83. PCG - Kolkata
1st Floor, Shree Laxmi Vilas Buildings, Kankaria Estate, 2nd Floor, 6-Little Russell Street,
G. B. Road, Palakkad- 678 014. Tel: (0491) 6450179 / 6450188. Vellore Kolkata - 700 071. Tel: (033) 22830055
20/B, First East Main Road, Land Mark Bldg, 2nd Floor,
Patiala Gandhi Nagar, Vellore-632006 Tel: (0416) 6454306 - 310.
SCO- 135, Chotti Baradari, Patiala -147 001 (PUNJAB) Sharekhan Representative Office
Vijaywada
Tel: (0175) 6622200 /01/02/03/04/05. Centurian Plaza, D. No: 40-1-129, 2nd Floor, Old Coolex Abudhabi
Pulgaon Building, M. G. Road, Vijaywada - 520 010. No:201-A Al Ain Jewellery Building (Sahara Abudhabi),
Khurana Complex, Near Balaji Hotel, Nachangoan Road, Tel: (0866) 6619992/6629993. Liwa Street, Abu Dhabi, UAE. Tel: 971-4-3963889.
Pulgaon - 442 302. Dubai
Vizag
Pune - F C Road 10-1-35/B, 3rd Flr, Parvathaneni House, Val Tair Uplands, 213, Nasir Lootah Bldg, Khalid Bin Walid Street (Bank
301, Millenium Plaza, 3rd Floor, Opp Fergusson College Vishakhapatman - 530003. Tel: (0891) 6673000/6671744. Street), P.O. Box: 120457, Dubai, U A E. Tel: 971-4-3963889
main Gate, Shivaji Nagar, Pune-4. Tel: (020) 66021301 - 06. Direct : 971-4-3963869.
Sharekhan ValueGuide 51 February 2010
February 2010 52 Sharekhan ValueGuide